Lichen ruber planus, wide definition including periferal and oral lichen planus

K11_LICHEN_PLANUS_WIDE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints K11_ORAL_LICHEN_PLANUS_INCLAVO L12_LICHENPLANUS_INCLAVO	8767
6. Filter based on genotype QC (FinnGen only)	8767

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF10

NAME	K11_LICHEN_PLANUS_WIDE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	K11_ORAL_LICHEN_PLANUS_INCLAVO\|L12_LICHENPLANUS_INCLAVO
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Lichen ruber planus, wide definition including periferal and oral lichen planus based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	49313	31731	17388
Only index persons	47551	30823	16728
Unadjusted period prevalence (%)
Whole population	0.76	0.91	0.49
Only index persons	0.96	1.13	0.64
Median age at first event (years)
Whole population	59.19	61.01	56.01
Only index persons	59.11	60.88	55.84

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8767	5919	2848
Unadjusted period prevalence (%)	1.77	2.02	1.26
Median age at first event (years)	60.78	60.99	60.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7703: Matched controls
77030

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D07AC13

ATC

mometasone; topical

2.8

323.0

3103

14855

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

+∞

323.0

1837

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

9.6

323.0

861

997

EKA10

NOMESCO Finland

Biopsy of cheek

28.7

323.0

1110

449

D07AD01

ATC

clobetasol; topical

5.5

323.0

2835

7402

L43.9

ICD-10 Finland

Lichen planus, unspecified

+∞

323.0

2800

L43.0

ICD-10 Finland

Hypertrophic lichen planus

+∞

323.0

755

L43

ICD-10 Finland

Lichen planus

+∞

323.0

1376

L43.8

ICD-10 Finland

Other lichen planus

+∞

323.0

2658

D07AC01

ATC

betamethasone; topical

4.4

323.0

4405

17963

L43.3

ICD-10 Finland

Subacute (active) lichen planus

+∞

285.1

272

SBA00

NOMESCO Finland

Microbiological examinations

9.4

277.0

603

693

E0000UV

ATC

2.4

271.3

3662

21248

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.9

263.7

1960

8102

SAA03

NOMESCO Finland

Extended examination of mouth

2.4

260.3

3507

20189

ECA20

NOMESCO Finland

Biopsy of gingiva

17.4

242.9

393

237

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

8.4

241.2

561

717

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

8.9

219.1

490

585

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.4

211.3

1176

3905

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.2

195.4

2576

14127

K13.29

ICD-10 Finland

Indefinite leukoplakia

13.8

193.3

343

259

D07AB02

ATC

hydrocortisone butyrate; topical

2.2

187.9

2589

14429

K13.78

ICD-10 Finland

Other change in the oral mucosa

8.1

186.5

440

571

L43.1

ICD-10 Finland

Bullous lichen planus

+∞

183.0

175

SAA01

NOMESCO Finland

Simple examination of mouth

2.0

174.2

5550

42911

SAA02

NOMESCO Finland

Basic examination of mouth

1.9

157.6

4992

37658

A07AA02

ATC

nystatin; oral

3.4

147.3

796

2543

SXA10

NOMESCO Finland

Epithel biopsy of mouth

10.9

147.1

291

276

A01AC01

ATC

triamcinolone; local oral

6.9

129.7

339

510

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.9

126.6

2761

17754

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

5.2

125.3

409

815

N77.8*L43.9

ICD-10 Finland

Vulvovaginal ulceration and inflammation caused by lichen ruber planus

143.4

119.5

127

E000001

ATC

2.1

118.8

1736

9560

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.9

114.0

1978

11621

L43.2

ICD-10 Finland

Lichenoid drug reaction

+∞

111.7

107

69700

ICD-8 Finland

Lichen, Planus

+∞

107.5

103

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

104.4

4233

32337

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

3.3

102.4

559

1783

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.7

101.3

4014

30348

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

4.1

100.4

414

1045

D05BB02

ATC

acitretin; oral

5.0

100.0

340

707

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.7

99.7

3486

25397

WX110

NOMESCO Finland

Local anesthesy

1.7

97.4

5172

42213

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.7

96.3

2846

19683

H02AB06

ATC

prednisolone; systemic

1.6

92.3

3610

26909

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

92.2

4268

33281

J02AC01

ATC

fluconazole; systemic

1.7

91.5

3220

23304

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

3.2

90.3

504

1630

D07AB08

ATC

desonide; topical

2.3

86.6

910

4271

L28.0

ICD-10 Finland

Lichen simplex chronicus

8.8

86.1

191

223

SDA02

NOMESCO Finland

Parodonthologic therapy

1.7

85.9

2527

17300

K13.20

ICD-10 Finland

Idiopathic leukoplakia

14.1

84.5

147

106

K02.1

ICD-10 Finland

Caries of dentine

1.6

84.4

4101

32046

ULA02

NOMESCO Finland

Kolposcopy

2.4

84.0

775

3409

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

78.1

3567

27222

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.3

78.0

820

3841

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

75.2

3051

22536

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.8

74.9

522

1953

A01AB09

ATC

miconazole; local oral

2.2

74.7

816

3884

R01AD11

ATC

triamcinolone; nasal

2.2

74.6

806

3816

Z01.2

ICD-10 Finland

Dental examination

1.6

74.1

3025

22354

D20

ICPC

Mouth/tongue/lip symptom/complaint

3.1

73.2

440

1496

R06AE07

ATC

cetirizine; oral

1.6

73.1

3253

24524

D09AB01

ATC

zinc bandage without supplements; topical

4.9

73.0

251

528

XQ802

NOMESCO Finland

Epicutan test

3.1

71.0

412

1366

B37.08

ICD-10 Finland

Other candidal stomatitis

9.8

68.4

142

148

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.7

66.8

1846

12232

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.5

65.6

3294

25317

R06AX27

ATC

desloratadine; oral

1.6

63.6

1940

13175

D07BC01

ATC

betamethasone and antiseptics; topical

2.0

63.4

971

5303

B37.03

ICD-10 Finland

Chronic atrophic candida infection in the mouth

17.9

62.7

R01AD09

ATC

mometasone; nasal

1.5

62.7

3273

25293

S29

ICPC

Skin symptom/complaint other

1.8

62.2

1310

7983

TQW80

NOMESCO Finland

Local dermatologic skincare

3.7

60.6

283

795

J01DB01

ATC

cefalexin; oral

1.6

59.1

6060

53946

KMAK

NOMESCO Finland

1.5

58.9

3680

29412

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.6

58.8

1888

12947

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

5.5

58.3

178

328

D82

ICPC

Teeth/gum disease

1.5

57.2

2415

17678

LEB00

NOMESCO Finland

Biopsy of vagina

4.3

55.5

216

516

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

53.8

2939

22683

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.6

53.2

1716

11728

XQ848

NOMESCO Finland

Dermatological photography

3.5

52.9

256

740

K13.28

ICD-10 Finland

Other leukoplakia or disorder of epithelium of the palate or tongue

12.6

52.9

R03AC02

ATC

salbutamol; inhalant

1.4

51.7

3760

30648

6970A

ICD-9 Finland

Lichen planus[LICHEN RUBER PLANUS]

+∞

51.1

K13.22

ICD-10 Finland

Erythroplakia of oral epithelium, including tongue

18.5

50.9

E000002

ATC

1.9

49.5

802

4445

D02AE01

ATC

carbamide; topical

2.2

49.2

544

2585

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.6

49.2

1764

12341

R06AE09

ATC

levocetirizine; oral

1.7

47.0

1044

6414

K03.64

ICD-10 Finland

Dental calculus supragingival

1.5

46.9

1901

13655

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.8

46.5

911

5380

R01AD08

ATC

fluticasone; nasal

1.5

46.3

2006

14618

A02BC05

ATC

esomeprazole; systemic

1.4

46.2

3019

23913

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.5

45.5

1761

12502

-1

NOMESCO Finland

1.5

45.4

2227

16651

S18

ICPC

Laceration/cut

1.4

45.2

3021

24006

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.5

45.0

374

1544

S21

ICPC

Skin texture symptom/complaint

1.8

44.7

917

5490

A01AB04

ATC

amphotericin B; local oral

2.3

44.5

426

1889

M79.6

ICD-10 Finland

Pain in limb

1.4

44.3

2576

19905

E000006

ATC

2.0

44.2

585

2998

K12.10

ICD-10 Finland

Stomatitis NOS

8.5

43.7

115

WZA90

NOMESCO Finland

Other doctors statement

1.5

43.7

1616

11340

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

2.2

42.8

482

2305

N76.3

ICD-10 Finland

Subacute and chronic vulvitis

6.6

42.2

111

170

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.8

41.6

853

5100

N77.8

ICD-10 Finland

Vulvovaginal ulceration and inflammation in other diseases classified elsewhere

40.3

41.5

J02AC02

ATC

itraconazole; systemic

1.6

41.2

1338

9085

A02BC02

ATC

pantoprazole; systemic

1.4

41.1

4761

41415

EBA00

NOMESCO Finland

Extraction of tooth

1.4

41.1

2196

16629

WX290

NOMESCO Finland

Other blockade of nerve

1.4

40.7

2838

22587

EJ2S1

NOMESCO Finland

Photography of oral mucosa

14.5

40.6

J01AA02

ATC

doxycycline; systemic

1.4

40.1

5776

52120

M25.5

ICD-10 Finland

Pain in joint

1.5

40.1

2026

15154

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.9

39.6

612

3324

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

39.5

799

4755

D19

ICPC

Teeth/gum symptom/complaint

1.5

39.1

1771

12943

EMAK

NOMESCO Finland

2.5

38.0

307

1246

M01AH05

ATC

etoricoxib; oral

1.4

37.8

4249

36505

N02BE01

ATC

paracetamol; systemic, rectal

1.5

37.4

6412

59287

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

5.2

37.4

119

232

K13.2

ICD-10 Finland

Leukoplakia and other disturbances of oral epithelium, including tongue

13.0

37.2

D07CC01

ATC

betamethasone and antibiotics; topical

1.7

37.0

908

5714

J01CA04

ATC

amoxicillin; systemic

1.4

36.7

5757

52179

SFA00

NOMESCO Finland

Small filling

1.7

36.7

915

5784

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

36.5

2045

15550

M03BX02

ATC

tizanidine; oral

1.4

36.4

4451

38651

D07XC01

ATC

betamethasone, combinations; topical

1.7

36.4

838

5175

TEA00

NOMESCO Finland

Biopsy of lip

4.7

36.0

125

268

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

10.7

35.9

K05.30

ICD-10 Finland

Periodontitis complex

1.7

35.8

893

5640

J01DA01

ATC

[U] cefalexin; systemic

1.4

35.6

4443

38636

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

35.4

1788

13310

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

35.2

902

5738

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

34.9

1474

10580

L17

ICPC

Foot/toe symptom/complaint

1.4

34.8

1764

13137

A98

ICPC

Health maint/preventive medicine

1.8

34.2

7288

69809

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

34.0

1804

13541

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

33.9

3007

24692

VALMI

NOMESCO Finland

1.5

33.6

1605

11799

R01AD12

ATC

fluticasone furoate; nasal

1.4

33.4

1927

14689

UJF32

NOMESCO Finland

Coloscopy

1.4

33.4

1824

13763

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

33.2

634

3695

EJB10

NOMESCO Finland

Excision of lesion of apex or body of tongue

7.5

32.6

105

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

32.5

1472

10696

A02BC03

ATC

lansoprazole; oral

1.4

32.4

2111

16428

SBB10

NOMESCO Finland

Teeth copy

2.1

32.3

383

1873

D07AC14

ATC

methylprednisolone aceponate; topical

2.2

32.2

357

1694

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.7

32.2

697

4219

K12.18

ICD-10 Finland

Other forms of stomatitis

5.5

32.1

179

C05AA08

ATC

fluocortolone; rectal, topical

1.6

31.9

1014

6808

E000007

ATC

2.0

31.8

409

2069

K05.31

ICD-10 Finland

Periodontitis pronounced

1.7

31.8

703

4284

SXC05

NOMESCO Finland

Other oral or dental procedure

2.1

31.4

384

1902

K12.00

ICD-10 Finland

Recurrent oral aphthae

4.0

30.9

127

322

H03AA01

ATC

levothyroxine sodium; systemic

1.4

30.8

1740

13175

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

30.6

3607

30772

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

30.5

1650

12390

EHA10

NOMESCO Finland

Biopsy of palate

5.6

30.1

160

J01FA10

ATC

azithromycin; systemic

1.3

30.0

3958

34280

M01AC06

ATC

meloxicam; systemic, rectal

1.3

29.9

2673

21842

SPAT1153

SPAT

Removal of sutures

1.4

29.8

2255

17944

R01AD01

ATC

beclometasone; nasal

1.5

29.4

1070

7404

D07AA02

ATC

hydrocortisone; topical

1.6

29.4

857

5623

N02AX02

ATC

tramadol; systemic, rectal

1.3

29.4

2930

24326

SPAT1263

SPAT

Sampling

1.3

29.2

2874

23804

G01AA10

ATC

clindamycin; vaginal

1.5

29.2

1046

7210

M54.5

ICD-10 Finland

Low back pain

1.4

29.1

2189

17387

L03

ICPC

Low back symptom/complaint

1.4

29.0

1615

12175

N89.5

ICD-10 Finland

Stricture and atresia of vagina

13.6

28.9

P01AB01

ATC

metronidazole; oral, rectal

1.3

28.8

2785

22993

R05

ICPC

Cough

1.4

28.7

1489

11078

SPAT1310

SPAT

Counselling related to known health issue

1.4

28.6

2174

17286

N03AX16

ATC

pregabalin; oral

1.4

28.5

1643

12460

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

28.4

2626

21522

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

28.3

6529

61274

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

28.0

601

3626

SPAT1312

SPAT

General health counselling

1.4

27.9

2110

16750

XQ800

NOMESCO Finland

Prick test

1.8

27.7

499

2847

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

27.6

1848

14371

SPAT1301

SPAT

No procedures

1.4

27.5

2133

16991

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.8

27.5

515

2979

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

27.4

3160

26702

L08

ICPC

Shoulder symptom/complaint

1.4

27.3

1299

9492

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.6

27.0

741

4786

L66.1

ICD-10 Finland

Lichen planopilaris

20.1

26.9

N48.1

ICD-10 Finland

Balanoposthitis

3.1

26.4

146

471

R06.0

ICD-10 Finland

Dyspnoea

1.4

26.3

1631

12503

S02

ICPC

Pruritus

2.4

26.3

226

950

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

26.2

1322

9762

L30.0

ICD-10 Finland

Nummular dermatitis

2.3

26.2

246

1083

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.4

25.8

227

968

SPAT1260

SPAT

Consultation of another employee

1.4

25.6

1199

8723

K02.0

ICD-10 Finland

Caries limited to enamel

1.6

25.5

784

5203

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

25.5

2323

18921

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

25.5

1535

11701

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

25.3

2018

16102

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

24.9

3401

29282

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.4

24.8

1428

10788

K05.1

ICD-10 Finland

Chronic gingivitis

1.8

24.5

462

2679

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

24.4

1648

12791

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

24.3

2173

17619

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

24.2

903

6259

R06AX22

ATC

ebastine; oral

1.4

24.2

1133

8235

8070/3-C02.1

ICD-O-3

Squamous cell carcinoma, NOS, of border of tongue

14.9

24.2

J01FF01

ATC

clindamycin; systemic

1.3

23.7

1791

14143

S08

ICPC

Skin colour change

1.9

23.6

349

1865

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.7

23.4

566

3528

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

23.2

785

5326

L15

ICPC

Knee symptom/complaint

1.4

23.0

1417

10815

N03AX12

ATC

gabapentin; oral

1.4

22.8

1033

7451

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

22.6

1022

7370

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

22.4

850

5909

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

22.4

1477

11395

R74

ICPC

Upper respiratory infection acute

1.3

22.4

1637

12846

A02BA02

ATC

ranitidine; systemic

1.4

22.3

1325

10046

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

22.3

2558

21418

M01AB05

ATC

diclofenac; systemic, rectal

1.3

22.3

4677

42254

N05BB01

ATC

hydroxyzine; systemic

1.8

22.3

411

2364

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.8

22.1

417

2415

EKC00

NOMESCO Finland

Suture of cheek

15.1

21.9

L28.1

ICD-10 Finland

Prurigo nodularis

4.2

21.6

195

J05AB01

ATC

aciclovir; systemic

1.4

21.6

1376

10545

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.4

21.6

1257

9493

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.4

21.5

1245

9390

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

11.9

21.4

EJ2S1

SPAT

43.4

21.4

L44.3

ICD-10 Finland

Lichen ruber moniliformis

43.4

21.4

D02AX

ATC

Other emollients and protectives

2.2

21.3

223

1033

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

21.2

2446

20459

SPAT1325

SPAT

Vaccination

1.3

21.1

2261

18723

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

3.5

21.1

284

TLE00

NOMESCO Finland

Dilatation of vagina

50.1

21.1

R13

ICD-10 Finland

Dysphagia

1.7

20.9

417

2459

J01MA02

ATC

ciprofloxacin; systemic

1.3

20.9

2523

21222

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

20.8

2907

24897

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

20.8

670

4489

M01AE02

ATC

naproxen; oral, rectal

1.3

20.7

3835

33980

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.0

20.4

283

1477

S99

ICPC

Skin disease other

2.6

20.4

154

607

R52.9

ICD-10 Finland

Pain, unspecified

1.6

20.4

546

3498

R05

ICD-10 Finland

Cough

1.4

20.2

1270

9699

L01

ICPC

Neck symptom/complaint

1.5

20.2

875

6246

D01BA02

ATC

terbinafine; oral; topical

1.3

20.2

1621

12870

N06AX11

ATC

mirtazapine; oral

1.3

20.1

2079

17113

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

20.0

1657

13214

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

3.1

19.9

111

363

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

19.8

1064

7910

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.8

19.7

335

1878

SBA10

NOMESCO Finland

Measurement of excretion of saliva

3.4

19.7

285

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

19.6

1862

15140

D05AX52

ATC

calcipotriol, combinations; topical

1.8

19.6

353

2019

J01FA09

ATC

clarithromycin; systemic

1.3

19.6

2085

17219

A02BC01

ATC

omeprazole; systemic

1.3

19.5

1826

14813

K03.66

ICD-10 Finland

Tooth plaque

1.7

19.5

405

2417

B37.00

ICD-10 Finland

Acute pseudomembraneuous candidal stomatitis

7.3

19.4

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

19.3

926

6740

L30.8

ICD-10 Finland

Other specified dermatitis

2.5

18.7

153

629

L20.0

ICD-10 Finland

Besnier prurigo

1.8

18.6

330

1876

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

18.6

1041

7790

M01AX17

ATC

nimesulide; oral

1.3

18.5

1694

13681

L13

ICPC

Hip symptom/complaint

1.4

18.5

1075

8097

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

18.4

480

3053

L57.0

ICD-10 Finland

Actinic keratosis

1.5

18.4

601

4041

M79.1

ICD-10 Finland

Myalgia

1.4

18.3

793

5656

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

18.3

642

4386

G47.3

ICD-10 Finland

Sleep apnoea

1.3

18.2

1297

10094

K13

ICD-10 Finland

Other diseases of lip and oral mucosa

7.3

18.1

M01AX05

ATC

glucosamine; oral

1.3

18.1

1452

11506

D07AC03

ATC

desoximetasone; topical

2.6

18.1

129

494

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

18.0

2788

24050

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.9

18.0

265

1415

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.5

18.0

691

4811

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

17.9

474

3024

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

17.7

1166

8956

N05CF02

ATC

zolpidem; oral

1.4

17.7

1154

8854

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

17.6

372

2233

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

17.6

776

5555

U02

ICPC

Urinary frequency/urgency

1.4

17.5

864

6315

K08.80

ICD-10 Finland

Toothache NOS

1.6

17.5

470

3012

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

17.4

875

6416

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.1

17.4

196

942

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

17.4

2568

21999

K07.60

ICD-10 Finland

Snapping jaw

1.8

17.2

292

1637

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

17.1

1180

9127

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

17.0

1202

9336

G44.2

ICD-10 Finland

Tension-type headache

1.4

17.0

817

5943

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

17.0

652

4535

M02AA07

ATC

piroxicam; topical

1.2

16.9

2502

21428

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.6

16.9

483

3143

K03.00

ICD-10 Finland

Approximal wear

1.8

16.8

305

1749

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

16.8

624

4310

J01FA06

ATC

roxithromycin; oral

1.2

16.8

2706

23395

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

16.7

1935

16085

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.5

16.7

556

3749

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.3

16.7

157

694

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.5

16.7

615

4242

K05.18

ICD-10 Finland

Chronic gingivitis

1.8

16.6

306

1761

L29.2

ICD-10 Finland

Pruritus vulvae

2.9

16.5

102

358

WKPAL

NOMESCO Finland

2.4

16.5

142

603

R05FB02

ATC

cough suppressants and expectorants

1.2

16.3

2543

21889

N90.8

ICD-10 Finland

Other specified noninflammatory disorders of vulva and perineum

3.7

16.3

189

N06AA09

ATC

amitriptyline; systemic

1.5

16.2

680

4818

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

16.2

518

3465

SXC03

NOMESCO Finland

Other oral or dental procedure

3.1

16.2

296

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.2

16.2

159

719

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.4

16.0

728

5236

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

16.0

680

4829

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

5.2

16.0

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.4

15.9

742

5369

K30

ICD-10 Finland

Functional dyspepsia

1.5

15.8

661

4679

R42

ICD-10 Finland

Dizziness and giddiness

1.3

15.8

1368

10929

L30.3

ICD-10 Finland

Infective dermatitis

2.0

15.8

204

1038

L93.0

ICD-10 Finland

Discoid lupus erythematosus

4.5

15.7

123

L29.9

ICD-10 Finland

Pruritus, unspecified

2.3

15.6

150

672

R51.80

ICD-10 Finland

Headache

1.4

15.6

847

6295

B35.3

ICD-10 Finland

Tinea pedis

1.9

15.5

231

1239

D06BX01

ATC

metronidazole; topical

1.4

15.5

672

4789

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

15.4

655

4656

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

15.3

720

5209

A02BC04

ATC

rabeprazole; oral

1.5

15.3

537

3665

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

15.2

1219

9630

J01FA15

ATC

telithromycin; oral

1.4

15.1

634

4491

N06AX21

ATC

duloxetine; oral

1.4

15.1

665

4757

P01BA02

ATC

hydroxychloroquine; oral

1.5

15.1

550

3787

SGA01

NOMESCO Finland

Tooth opening as first aid

1.4

15.1

890

6709

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

2.6

15.0

110

429

A07EA02

ATC

hydrocortisone; rectal

2.2

15.0

151

690

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

15.0

344

2116

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

14.9

2692

23469

K14.61

ICD-10 Finland

Glossodynia

3.5

14.9

204

EAA10

NOMESCO Finland

Excision of lesion of lip

2.9

14.8

319

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

14.8

586

4105

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

14.8

498

3369

EKB00

NOMESCO Finland

Excision of lesion of cheek

4.5

14.7

113

KGB00

NOMESCO Finland

Biopsy of penis

16.5

14.7

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

14.7

380

2411

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

14.7

1549

12698

EDB00

NOMESCO Finland

Partial excision of mandible

8.6

14.7

D07AB01

ATC

clobetasone; topical

1.9

14.6

204

1071

L30

ICD-10 Finland

Other dermatitis

2.3

14.6

132

574

R09

ICPC

Sinus symptom/complaint

1.5

14.5

451

2992

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

2.9

14.5

310

G04BD12

ATC

mirabegron; oral

1.4

14.5

642

4597

K13.7

ICD-10 Finland

Other and unspecified lesions of oral mucosa

5.8

14.4

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.5

14.4

458

3060

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.7

14.4

275

1604

EBB10

NOMESCO Finland

Insertion of dental implant

2.6

14.3

101

386

N06AX16

ATC

venlafaxine; oral

1.4

14.2

806

6027

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.7

14.2

317

1937

XQ845

NOMESCO Finland

Dermatoscopy

2.8

14.2

333

R03BA05

ATC

fluticasone; inhalant

1.3

14.2

1091

8561

H02AB04

ATC

methylprednisolone; systemic

1.3

14.2

927

7100

K13.21

ICD-10 Finland

Leukoplakia caused by tobacco

6.5

14.1

A03

ICPC

Fever

1.4

14.0

821

6174

PAD

NOMESCO Finland

10.9

14.0

B37.0

ICD-10 Finland

Candidal stomatitis

2.9

14.0

281

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

13.9

816

6135

B37.01

ICD-10 Finland

Acute athrophy candidal stomatitis

6.3

13.9

J01AA04

ATC

lymecycline; systemic

1.4

13.8

718

5294

S87

ICPC

Dermatitis/atopic eczema

2.3

13.7

127

561

S06

ICPC

Rash localized

1.6

13.6

339

2133

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

13.6

1085

8554

N76.6

ICD-10 Finland

Ulceration of vulva

3.5

13.6

182

SFC92

NOMESCO Finland

Other demanding adjuvant procedure of filling therapy

1.6

13.6

395

2585

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

13.6

1062

8348

EJB40

NOMESCO Finland

Hemiglossectomy

10.9

13.5

K03.80

ICD-10 Finland

Irradiated enamel

1.7

13.5

270

1597

R06AX13

ATC

loratadine; oral

1.3

13.4

899

6914

K11.70

ICD-10 Finland

Hypoptyalism

3.5

13.3

170

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

13.3

625

4527

K13.1

ICD-10 Finland

Cheek and lip biting

4.1

13.2

122

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

13.2

390

2561

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

13.1

953

7407

A01AB10

ATC

natamycin; local oral

1.9

13.0

178

929

F29

ICPC

Eye symptom/complaint other

1.5

13.0

484

3347

K05.12

ICD-10 Finland

Gingivitis (chronic) simple marginal

10.9

13.0

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

13.0

1440

11852

C06.0

ICD-10 Finland

Malignant neoplasm: Cheek mucosa

10.0

12.9

R03BA01

ATC

beclometasone; inhalant

1.3

12.9

870

6689

H02AB07

ATC

prednisone; oral

1.3

12.9

885

6821

L02

ICPC

Back symptom/complaint

1.5

12.8

516

3622

A07EA06

ATC

budesonide; oral, local oral

1.8

12.8

203

1117

D11

ICPC

Diarrhoea

1.4

12.8

589

4246

L14

ICPC

Leg/thigh symptom/complaint

1.5

12.8

438

2973

R60.0

ICD-10 Finland

Localized oedema

1.4

12.7

650

4773

H60.8

ICD-10 Finland

Other otitis externa

2.0

12.7

161

817

N01

ICPC

Headache

1.5

12.6

495

3456

R21

ICPC

Throat symptom/complaint

1.3

12.6

1021

8066

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.4

12.5

104

436

N90.9

ICD-10 Finland

Noninflammatory disorder of vulva and perineum, unspecified

3.8

12.5

138

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

12.5

901

6995

M48.0

ICD-10 Finland

Spinal stenosis

1.4

12.5

748

5647

LFA00

NOMESCO Finland

Incision of vulva or perineum

6.6

12.4

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.9

12.4

193

1054

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.4

12.4

590

4280

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.4

12.3

573

4139

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

3.7

12.3

140

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.0

12.3

149

744

R96

ICPC

Asthma

1.4

12.3

542

3875

N76.0

ICD-10 Finland

Acute vaginitis

1.7

12.2

245

1453

K14.60

ICD-10 Finland

Glossopyrosis

3.8

12.2

136

K14.1

ICD-10 Finland

Geographic tongue

3.7

12.2

141

R03BA02

ATC

budesonide; inhalant

1.3

12.2

1046

8324

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

12.2

624

4585

SPAT1097

SPAT

Recording of ECG

1.3

12.1

925

7239

K05.19

ICD-10 Finland

Gingivitis (chronic) ulcerative

2.1

12.1

131

622

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

12.1

343

2228

R03DC03

ATC

montelukast; oral

1.3

12.1

961

7567

N90.4

ICD-10 Finland

Leukoplakia of vulva

4.3

12.0

100

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

12.0

568

4114

104

Kela drug reimbursment

Thyroid insufficiency

1.4

11.9

490

3457

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

4.1

11.9

110

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.2

11.9

1668

14087

KGH10

NOMESCO Finland

Operation for phimosis

2.2

11.9

115

522

D83

ICPC

Mouth/tongue/lip disease

3.9

11.9

125

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

11.8

323

2082

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.5

11.8

419

2867

R07.0

ICD-10 Finland

Pain in throat

1.6

11.8

326

2107

J01EA01

ATC

trimethoprim; systemic

1.2

11.8

1614

13591

P03

ICPC

Feeling depressed

1.5

11.8

433

2988

K05.08

ICD-10 Finland

Another acute gingivitis

2.1

11.8

133

644

S01

ICPC

Pain/tenderness of skin

1.7

11.7

250

1508

G04CA02

ATC

tamsulosin; oral

1.3

11.7

973

7708

M01AX01

ATC

nabumetone; oral

1.6

11.7

283

1770

L12

ICPC

Hand/finger symptom/complaint

1.3

11.7

836

6482

SGB30

NOMESCO Finland

Other demanding filling of root channel of tooth

1.4

11.7

589

4318

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

11.6

538

3885

8070/3-C06.0

ICD-O-3

Squamous cell carcinoma, NOS, of cheeck mucosa

18.9

11.6

D07XB05

ATC

dexamethasone, combinations; topical

1.9

11.5

158

827

L50.3

ICD-10 Finland

Dermatographic urticaria

2.3

11.5

101

437

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.4

11.5

654

4890

C03.0

ICD-10 Finland

Malignant neoplasm: Upper gum

13.6

11.4

H13

ICPC

Plugged feeling ear

1.3

11.4

1047

8406

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

11.4

699

5293

L28

ICPC

Limited function/disability (L)

1.3

11.4

935

7392

UKC02

NOMESCO Finland

Cystoscopy

1.3

11.4

867

6785

J05AB11

ATC

valaciclovir; oral

1.3

11.4

803

6214

M79.7

ICD-10 Finland

Fibromyalgia

1.8

11.4

201

1149

SDA05

NOMESCO Finland

Very demanding and lengthy parodonthologic therapy

1.6

11.3

291

1849

H29

ICPC

Ear symptom/complaint other

1.4

11.3

592

4368

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

11.3

303

1945

R02

ICPC

Shortness of breath/dyspnoea

1.4

11.3

699

5299

L73.8

ICD-10 Finland

Other specified follicular disorders

3.3

11.3

167

K13.03

ICD-10 Finland

Keilit UNS

5.2

11.3

A04

ICPC

Weakness/tiredness general

1.3

11.3

709

5391

D01AC02

ATC

miconazole; topical

1.4

11.2

450

3161

B37.02

ICD-10 Finland

Chronic hyperplastic candidal stomatitis

8.9

11.2

R35

ICD-10 Finland

Polyuria

1.5

11.2

330

2168

B35.1

ICD-10 Finland

Tinea unguium

1.6

11.2

311

2013

M54.2

ICD-10 Finland

Cervicalgia

1.5

11.2

404

2778

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

11.2

531

3850

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

11.2

930

7365

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

11.2

466

3299

D01AE15

ATC

terbinafine; topical

1.5

11.1

388

2649

E000003

ATC

1.6

11.1

262

1630

E03

ICD-10 Finland

Other hypothyroidism

1.5

11.1

364

2451

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.0

11.0

134

670

K60.1

ICD-10 Finland

Chronic anal fissure

2.0

11.0

134

672

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.4

11.0

470

3343

SGA05

NOMESCO Finland

Very demanding and lengthy opening and dilatation of root canal of tooth

1.6

10.9

308

2000

J01AA07

ATC

tetracycline; systemic

1.3

10.9

837

6555

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

10.8

1039

8382

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

10.8

2160

18877

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

10.8

478

3421

ECA30

NOMESCO Finland

Excision of lesion of gingiva

2.6

10.8

292

SPAT1058

SPAT

PEF monitoring instruction

1.4

10.8

503

3635

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.0

10.7

141

728

Z71.8

ICD-10 Finland

Other specified counselling

1.2

10.7

1364

11385

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.0

10.7

127

629

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

10.7

367

2499

N06AB04

ATC

citalopram; systemic

1.2

10.7

1318

10965

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.5

10.6

395

2732

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

10.5

697

5341

N05BA04

ATC

oxazepam; oral

1.2

10.5

1499

12667

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.6

10.5

238

1467

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

1.4

10.4

470

3377

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

10.4

2244

19733

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

10.4

1133

9282

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

10.4

290

1880

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.6

10.4

265

1682

L71.0

ICD-10 Finland

Perioral dermatitis

2.5

10.4

305

B81

ICPC

Anaemia vit B12/folate deficiency

1.7

10.3

208

1239

J01CA08

ATC

pivmecillinam; oral

1.2

10.3

2686

24017

A11

ICPC

Chest pain NOS

1.4

10.3

436

3095

R03AC03

ATC

terbutaline; inhalant

1.3

10.3

825

6500

L12.0

ICD-10 Finland

Bullous pemphigoid

3.6

10.2

122

B86

ICD-10 Finland

Scabies

2.4

10.2

347

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

10.2

4502

42024

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.5

10.2

340

2301

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

10.2

1284

10702

T84.60

ICD-10 Finland

Gingivitis associated with dental implants

3.3

10.1

149

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.4

10.1

418

2955

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.3

10.1

828

6546

K14.9

ICD-10 Finland

Disease of tongue, unspecified

4.4

10.1

R06.5

ICD-10 Finland

Mouth breathing

1.4

10.1

462

3332

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

10.0

1597

13636

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.2

10.0

443

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.7

10.0

203

1211

J01MA06

ATC

norfloxacin; oral

1.3

10.0

828

6549

E000004

ATC

2.0

10.0

122

611

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.3

10.0

681

5241

SPAT1043

SPAT

Audiometry

1.3

9.9

605

4575

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.7

9.9

210

1269

H01

ICPC

Ear pain/earache

1.4

9.9

574

4309

N17

ICPC

Vertigo/dizziness

1.3

9.9

640

4889

L44.1

ICD-10 Finland

Lichen nitidus

20.0

9.8

R03BA08

ATC

ciclesonide; inhalant

1.4

9.7

478

3489

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

9.6

397

2806

M01AH02

ATC

rofecoxib; oral

1.3

9.6

830

6602

L29.0

ICD-10 Finland

Pruritus ani

2.8

9.6

206

A46

ICD-10 Finland

Erysipelas

1.3

9.6

766

6029

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

3.5

9.6

119

J45

ICD-10 Finland

Asthma

1.4

9.6

560

4209

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.2

9.5

440

A03FA02

ATC

cisapride; oral, rectal

1.4

9.5

458

3330

A02BA04

ATC

nizatidine; systemic

1.4

9.5

451

3274

M54

ICD-10 Finland

Dorsalgia

1.3

9.5

614

4689

A01

ICPC

Pain general/multiple sites

1.4

9.5

444

3215

K02.2

ICD-10 Finland

Caries of cementum

1.6

9.4

243

1552

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

9.4

332

2275

XKD00

NOMESCO Finland

Uroflowmetry

1.3

9.4

720

5640

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.5

9.4

286

1899

L20.8

ICD-10 Finland

Other atopic dermatitis

2.7

9.3

237

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

9.3

807

6423

Z70.8

ICD-10 Finland

Other sex counselling

5.5

9.3

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

9.2

1111

9199

C07AA05

ATC

propranolol; systemic

1.2

9.2

1133

9401

S88

ICPC

Dermatitis contact/allergic

2.0

9.2

116

590

SPAT1336

SPAT

Request for examination

1.6

9.2

207

1275

EJW99

NOMESCO Finland

Other operation on tongue or floor of mouth

13.7

9.2

S22

ICPC

Nail symptom/complaint

1.5

9.2

309

2099

D01

ICPC

Abdominal pain/cramps general

1.3

9.1

573

4352

K13.09

ICD-10 Finland

Disease of the lips UNS

6.2

9.1

N05CF01

ATC

zopiclone; oral

1.2

9.0

2036

17934

D01AE16

ATC

amorolfine; topical

1.3

9.0

708

5560

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

8.9

613

4720

WX110

SPAT

1.6

8.9

239

1537

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.3

8.9

566

4313

P06

ICPC

Sleep disturbance

1.3

8.9

527

3974

L71.8

ICD-10 Finland

Other rosacea

2.2

8.9

395

N06AB03

ATC

fluoxetine; oral

1.3

8.8

739

5852

S02.51

ICD-10 Finland

Fracture of tooth, open

1.3

8.8

573

4375

J01MA12

ATC

levofloxacin; systemic

1.2

8.8

1055

8728

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.2

8.8

1206

10125

S82

ICPC

Naevus/mole

1.3

8.8

675

5285

B37

ICD-10 Finland

Candidiasis

4.9

8.8

J33.0

ICD-10 Finland

Polyp of nasal cavity

1.8

8.7

150

854

C10AX09

ATC

ezetimibe; oral

1.3

8.7

639

4975

N06AB10

ATC

escitalopram; oral

1.2

8.7

1096

9126

K95

ICPC

Varicose veins of leg

2.2

8.7

406

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

8.6

274

1836

K10.3

ICD-10 Finland

Alveolitis of jaws

1.6

8.6

217

1379

L29.8

ICD-10 Finland

Other pruritus

2.4

8.6

277

UJH02

NOMESCO Finland

Anoscopy

1.5

8.6

245

1602

H93.1

ICD-10 Finland

Tinnitus

1.4

8.6

363

2578

H92.0

ICD-10 Finland

Otalgia

1.5

8.6

272

1820

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

8.6

599

4628

L50.9

ICD-10 Finland

Urticaria, unspecified

1.7

8.5

180

1088

G03CA04

ATC

estriol; systemic, vaginal

1.4

8.5

463

3439

K07

ICPC

Swollen ankles/oedema

1.6

8.5

235

1525

J01FA01

ATC

erythromycin; systemic

1.3

8.5

739

5879

Z00.0

ICD-10 Finland

General medical examination

1.2

8.5

1047

8689

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

1.5

8.4

278

1877

M45

ICD-10 Finland

Ankylosing spondylitis

1.9

8.4

110

568

R52.2

ICD-10 Finland

Other chronic pain

1.7

8.4

184

1123

C10AC01

ATC

colestyramine; oral

1.7

8.4

153

887

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

8.4

752

6005

SPA30

NOMESCO Finland

Grinding of a single crown and bridge pillar or a single post and crown

2.5

8.4

266

R49.08

ICD-10 Finland

Other specified dysphonia

1.8

8.3

126

690

K14.69

ICD-10 Finland

Tongue pain UNS

3.3

8.3

123

A07EC02

ATC

mesalazine; oral, rectal

1.5

8.3

285

1942

L82

ICD-10 Finland

Seborrhoeic keratosis

1.2

8.3

945

7774

L28.2

ICD-10 Finland

Other prurigo

3.6

8.3

8070/3-C02.9

ICD-O-3

Squamous cell carcinoma, NOS, of tongue, NOS

8.5

8.3

DFF00

NOMESCO Finland

Pure tone audiometry

1.3

8.3

506

3829

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

8.3

607

4724

SPAT1240

SPAT

Therapeutic discussion

1.3

8.3

515

3913

R01AD05

ATC

budesonide; nasal

1.4

8.3

444

3295

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

8.2

708

5628

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

8.2

666

5250

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

8.2

296

2040

K12

ICD-10 Finland

Stomatitis and related lesions

4.7

8.2

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

2.5

8.2

238

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

1.5

8.2

266

1793

UDC00

NOMESCO Finland

Ear microscopy

1.4

8.2

389

2829

R07

ICPC

Sneezing/nasal congestion

1.5

8.1

292

2009

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

8.1

831

6752

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.3

8.1

510

3880

WX002

NOMESCO Finland

Sedation and analgesia

1.2

8.1

1200

10153

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

8.1

489

3697

SCF02

NOMESCO Finland

Preventive oral care by dental hygienist

1.7

8.1

155

913

N81.6

ICD-10 Finland

Rectocele

1.4

8.1

436

3238

S15

ICPC

Foreign body in skin

1.4

8.1

345

2460

N48.5

ICD-10 Finland

Ulcer of penis

8.1

A97

ICPC

No disease

1.3

8.1

815

6611

SPA41

NOMESCO Finland

Precision impression for fixed dental prosthesis

2.3

8.0

330

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.0

8.0

504

U07

ICPC

Urine symptom/complaint other

1.4

8.0

329

2328

EEB00

NOMESCO Finland

Partial excision of maxilla

10.0

8.0

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

1.9

8.0

105

547

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.3

8.0

702

5598

N76.8

ICD-10 Finland

Other specified inflammation of vagina and vulva

2.4

8.0

282

K07.23

ICD-10 Finland

Deep bite

2.0

8.0

448

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.4

7.9

378

2753

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.7

7.9

158

945

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

4.5

7.8

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.4

7.8

401

2954

LEA10

NOMESCO Finland

Colpotomy

10.8

7.8

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

7.8

1674

14661

R07.3

ICD-10 Finland

Other chest pain

1.3

7.8

522

4013

ZXA05

NOMESCO Finland

Left side

1.2

7.7

1571

13684

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.3

7.7

537

4143

ZXA00

NOMESCO Finland

Right side

1.2

7.7

1680

14721

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.3

7.7

561

4360

D10.39

ICD-10 Finland

Benign tumor in other or unspecified part of oral cavity UNS

3.7

7.7

A60

ICPC

General and Unspecified, Result test/procedure

1.5

7.7

235

1565

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.4

7.7

299

2091

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.3

7.7

688

5498

N03AX09

ATC

lamotrigine; oral

1.5

7.7

215

1404

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

7.7

383

2805

EBB15

NOMESCO Finland

Insertion of dental implant abutment

2.6

7.7

204

M01AG02

ATC

tolfenamic acid; oral, rectal

1.2

7.7

909

7512

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.6

7.6

199

1277

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.3

7.6

548

4252

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.6

7.6

205

1326

N06AX26

ATC

vortioxetine; oral

1.5

7.6

252

1709

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.4

7.6

312

2205

N39.3

ICD-10 Finland

Stress incontinence

1.3

7.6

456

3443

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

1.8

7.6

125

704

L44.2

ICD-10 Finland

Lichen striatus

18.4

7.6

H01.0

ICD-10 Finland

Blepharitis

1.5

7.6

282

1957

ZX198

NOMESCO Finland

Other local administration

2.4

7.6

251

R12

ICD-10 Finland

Heartburn

1.4

7.6

391

2882

HMAK

NOMESCO Finland

1.3

7.6

655

5212

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

7.5

196

1255

I10

ICD-10 Finland

Essential (primary) hypertension

1.1

7.5

3816

35601

L12.8

ICD-10 Finland

Other pemphigoid

8.8

7.5

Y04

ICPC

Penis symptom/complaint other

3.6

7.5

D02

ICPC

Abdominal pain epigastric

1.4

7.5

315

2237

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

7.5

1109

9378

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.0

7.5

417

L04

ICPC

Chest symptom/complaint

1.4

7.5

309

2189

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

7.4

602

4746

I84.5

ICD-10 Finland

External hemorrhoids without complication

1.6

7.4

177

1109

L40.8

ICD-10 Finland

Other psoriasis

2.5

7.4

211

L28

ICD-10 Finland

Lichen simplex chronicus and prurigo

2.5

7.4

211

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.4

7.4

284

1985

A07EC01

ATC

sulfasalazine; oral, rectal

1.3

7.4

453

3435

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.3

7.4

453

3435

ICD-10 Finland

1.7

7.4

134

777

K90.0

ICD-10 Finland

Coeliac disease

1.7

7.4

155

941

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.3

7.4

673

5391

X15

ICPC

Vaginal symptom/complaint other

1.7

7.4

148

887

S76

ICPC

Skin infection other

1.5

7.3

266

1836

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.2

7.3

971

8115

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.3

7.3

636

5063

L42

ICD-10 Finland

Pityriasis rosea

3.5

7.3

G03CC04

ATC

estrone; systemic

1.6

7.3

200

1297

L16

ICPC

Ankle symptom/complaint

1.3

7.3

550

4292

Y29

ICPC

Genital symptom/complaint male other

3.9

7.3

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

7.3

351

2557

SPC01

NOMESCO Finland

Fixed dental crown

2.2

7.3

334

K80

ICPC

Cardiac arrhythmia NOS

1.4

7.3

411

3074

R83

ICPC

Respiratory infection other

1.2

7.3

1178

10046

D01AA02

ATC

natamycin; topical

1.8

7.3

113

625

8070/3-C03.1

ICD-O-3

Squamous cell carcinoma, NOS, of lower gum

10.8

7.3

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

7.3

692

5571

EJB99

NOMESCO Finland

Other excision on tongue and floor of mouth

9.3

7.3

D03

ICPC

Heartburn

1.6

7.2

167

1038

A99

ICPC

Disease/condition unspecnature/site

1.3

7.2

428

3225

-60

ICPC

Result test/procedure

1.4

7.2

311

2225

K04.08

ICD-10 Finland

Other specified pulpit

1.4

7.2

301

2140

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.3

7.2

438

3320

M02AA10

ATC

ketoprofen; topical

1.2

7.2

957

8004

D06BB03

ATC

aciclovir; topical

1.4

7.2

278

1945

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.0

7.1

401

L57.8

ICD-10 Finland

Other skin changes due to chronic exposure to nonionizing radiation

3.7

7.1

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.3

7.1

596

4725

N51.8*A60.0

ICD-10 Finland

Herpes simplex infection of the genitals in men

7.9

7.1

Z01.7

ICD-10 Finland

Laboratory examination

1.3

7.1

594

4707

SPAT1081

SPAT

Cardiorespiratory global assessment

1.4

7.1

316

2276

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.1

7.1

382

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.7

7.0

138

821

P20

ICPC

Memory disturbance

1.3

7.0

630

5037

C10AA04

ATC

fluvastatin; oral

1.3

7.0

477

3675

SPAT1283

SPAT

Restricted health certificate

1.2

7.0

746

6094

EBA10

NOMESCO Finland

Surgical removal of tooth

1.3

7.0

527

4120

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.5

7.0

261

1817

SFC00

NOMESCO Finland

Pillar of fillings material

1.6

6.9

161

1006

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

2.1

6.9

323

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

2.4

6.9

239

K11.2

ICD-10 Finland

Sialoadenitis

1.6

6.9

170

1078

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

1.9

6.9

472

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

6.9

367

2723

SPAT1211

SPAT

Application of soft bandage

1.3

6.9

490

3799

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.5

6.8

235

1608

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.6

6.8

174

1110

M01AH03

ATC

valdecoxib; oral

1.4

6.8

370

2752

L27.1

ICD-10 Finland

Localized skin eruption due to drugs and medicaments

3.3

6.8

H02.3

ICD-10 Finland

Blepharochalasis

1.4

6.8

367

2732

R60.9

ICD-10 Finland

Oedema, unspecified

1.5

6.8

250

1737

R06.2

ICD-10 Finland

Wheezing

1.5

6.8

216

1453

D06

ICPC

Abdominal pain localized other

1.3

6.7

432

3300

QBA

NOMESCO Finland

Incision or local destruction of lesion of skin of trunk

16.7

6.7

U05

ICPC

Urination problems other

1.5

6.7

229

1563

K59.0

ICD-10 Finland

Constipation

1.4

6.7

293

2102

A08

ICPC

Swelling

1.5

6.7

223

1515

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

6.7

547

4321

M67.4

ICD-10 Finland

Ganglion

1.4

6.7

340

2502

ZZQ20

NOMESCO Finland

Free microvascular graft of skin, muscle and bone

22.5

6.7

H00.1

ICD-10 Finland

Chalazion

1.6

6.7

177

1143

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.5

6.7

209

1401

M19.8

ICD-10 Finland

Other specified arthrosis

1.5

6.7

191

1257

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

2.1

6.6

314

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.6

6.6

175

1127

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

6.6

626

5039

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.5

6.6

204

1364

ECB00

NOMESCO Finland

Suture of gingiva

1.6

6.6

175

1131

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

6.6

359

2674

LCA06

NOMESCO Finland

Biopsy of endometrium

1.2

6.6

696

5675

X16

ICPC

Vulval symptom/complaint

2.2

6.6

284

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.1

6.6

305

L12.1

ICD-10 Finland

Cicatricial pemphigoid

12.2

6.6

J30.3

ICD-10 Finland

Other allergic rhinitis

1.6

6.6

163

1035

1412

FHL

Laparoscopy and sterilization

1.3

6.6

472

3665

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.2

6.6

693

5650

SPF10

NOMESCO Finland

Demanding repatation of teeth prosthesis

1.8

6.5

112

641

G01AF01

ATC

metronidazole; vaginal

1.3

6.5

624

5029

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

6.5

338

2496

C02.10

ICD-10 Finland

Malignant neoplasm of tip of tongue

10.0

6.5

ZXC10

NOMESCO Finland

Use of laser

1.7

6.5

121

711

T78.3

ICD-10 Finland

Angioneurotic oedema

2.0

6.5

368

K13.00

ICD-10 Finland

Cheilitis NOS

3.1

6.5

102

XF402

NOMESCO Finland

ECG with work load test

1.3

6.5

633

5112

L20

ICD-10 Finland

Atopic dermatitis

1.8

6.5

548

L11

ICPC

Wrist symptom/complaint

1.3

6.5

407

3099

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.3

6.5

472

3671

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.4

6.5

365

2732

U01

ICPC

Dysuria/painful urination

1.3

6.5

408

3107

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.6

6.5

143

884

K05.0

ICD-10 Finland

Acute gingivitis

1.7

6.5

115

667

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.1

6.5

335

M01AB08

ATC

etodolac; oral

1.3

6.4

425

3266

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.3

6.4

655

5322

E0001A1

ATC

1.9

6.4

485

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

1.7

6.4

130

784

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

2.2

6.4

273

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.7

6.4

116

678

R03AC13

ATC

formoterol; inhalant

1.4

6.4

262

1861

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.5

6.4

183

1206

R20.2

ICD-10 Finland

Paraesthesia of skin

1.4

6.4

334

2473

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

2.1

6.4

317

SPA02

NOMESCO Finland

Preparation for dental prosthetics

1.7

6.4

121

716

D11AH01

ATC

tacrolimus; topical

2.6

6.3

161

XKC03

NOMESCO Finland

Water cystometry

1.5

6.3

181

1190

SPAT1281

SPAT

Other administrative function

1.3

6.3

416

3192

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.3

6.3

556

4436

P01

ICPC

Feeling anxious/nervous/tense

1.3

6.3

418

3208

Z02.4

ICD-10 Finland

Examination for driving licence

1.2

6.3

1251

10863

J37.0

ICD-10 Finland

Chronic laryngitis

1.6

6.3

165

1064

B48.8

ICD-10 Finland

Other specified mycoses

5.5

6.3

R04.0

ICD-10 Finland

Epistaxis

1.4

6.3

354

2651

EBB11

NOMESCO Finland

Insertion of additional dental implant in one session

2.5

6.3

180

107

Kela drug reimbursment

Pernicious anaemia

1.8

6.3

100

559

R44

ICPC

Respiratory, Preventive immunization/medic

1.9

6.3

453

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

2.9

6.3

125

J34.2

ICD-10 Finland

Deviated nasal septum

1.4

6.3

252

1783

G03CB01

ATC

dienestrol; oral, vaginal

1.6

6.3

163

1049

R30.0

ICD-10 Finland

Dysuria

1.5

6.2

180

1185

N30

ICD-10 Finland

Cystitis

1.3

6.2

389

2962

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.3

6.2

479

3756

I49.1

ICD-10 Finland

Atrial premature depolarization

1.5

6.2

183

1212

L29

ICD-10 Finland

Pruritus

2.1

6.2

313

M54.8

ICD-10 Finland

Other dorsalgia

1.5

6.2

210

1435

G03FB05

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

1.2

6.2

769

6381

EB1MA

NOMESCO Finland

Cephalometry with X-ray

1.9

6.2

430

A06AD11

ATC

lactulose; oral

1.2

6.2

736

6081

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

2.0

6.2

352

H02

ICPC

Hearing complaint

1.2

6.2

669

5468

XQ899

NOMESCO Finland

Other assessment of skin

3.0

6.2

106

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

1.7

6.2

128

775

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.1

6.2

328

M77.4

ICD-10 Finland

Metatarsalgia

1.4

6.2

296

2159

SPC10

NOMESCO Finland

Attachment of standard crone of tooth

1.8

6.1

103

587

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

2.1

6.1

285

R39.1

ICD-10 Finland

Other difficulties with micturition

1.6

6.1

136

840

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

6.1

216

1488

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

2.0

6.1

343

K04

ICPC

Palpitations/awareness of heart

1.4

6.1

271

1952

R29

ICPC

Respiratory symptom/complaint other

1.4

6.1

325

2413

S01.50

ICD-10 Finland

Open wound in oral cavity

2.2

6.1

254

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

1.7

6.1

110

642

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

2.2

6.1

275

H10

ICD-10 Finland

Conjunctivitis

1.4

6.1

298

2184

SPC20

NOMESCO Finland

Attachment of crone of tooth to implant

2.4

6.1

185

ELB10

NOMESCO Finland

Excision of minor salivary gland

4.0

6.1

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.5

6.1

172

1131

D07CB01

ATC

triamcinolone and antibiotics; topical

1.7

6.1

120

719

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

6.0

324

2409

E66.01

ICD-10 Finland

Obesity due to excess calories

1.3

6.0

379

2886

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

1.9

6.0

402

N76.2

ICD-10 Finland

Acute vulvitis

2.9

6.0

114

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

6.0

309

2283

N04BC05

ATC

pramipexole; oral

1.3

6.0

412

3180

G43.9

ICD-10 Finland

Migraine, unspecified

1.4

6.0

236

1661

L21.0

ICD-10 Finland

Seborrhoea capitis

2.2

6.0

248

L73.9

ICD-10 Finland

Follicular disorder, unspecified

3.3

6.0

R53

ICD-10 Finland

Malaise and fatigue

1.2

6.0

1102

9500

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3026389) Candida sp identified in Specimen by Organism specific culture

600

1049

6.07

307.65

1.9

1.3

—

(40768443) Skin Pathology biopsy report

1175

3359

3.88

307.65

1.3

1.2

—

(3000494) Fungus identified in Specimen by Culture

1649

8909

2.05

134.03

1.7

1.4

—

(40768804) Tissue Pathology biopsy report

4292

31420

1.72

129.07

2.4

2.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

228

560

4.15

83.06

1.5

u/ml

19.8

20.0

0.03

113

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

205

464

4.50

83.03

1.3

titre

50.9

59.1

0.22

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

208

483

4.39

81.55

1.3

titre

443.0

339.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

6519

56326

1.61

79.22

4.7

4.2

mm/h

12.3

12.8

2.13

6042

52086

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6697

58588

1.61

73.61

4.8

4.2

pmol/l

14.8

14.9

0.51

6080

53193

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2293

16109

1.57

69.09

1.3

u/ml

1.6

1.8

0.28

637

4222

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7616

69219

1.76

68.22

5.8

5.0

mu/l

2.2

2.1

0.16

6996

63282

(3037522) Nuclear Ab [Titer] in Serum

1546

10330

1.60

56.06

1.5

1.3

titre

544.9

539.4

0.04

347

2240

(3037467) Urinalysis macro (dipstick) panel - Urine

5916

51645

1.45

54.07

5.0

4.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1960

13957

1.52

53.22

1.4

1.5

g/l

2.5

0.10

1163

8228

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6590

59021

1.47

50.19

7.8

7.7

u/l

76.8

78.5

2.52

6215

55503

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3865

31593

1.40

49.43

2.1

2.0

pmol/l

96.5

97.0

0.23

1904

15790

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7949

74375

1.74

48.32

15.4

14.6

mg/l

21.0

23.4

9.14

6391

59105

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7532

69683

1.57

46.00

6.4

5.9

mmol/mol

39.9

39.8

0.04

6967

64234

(3013115) Eosinophils [#/volume] in Blood

4576

38757

1.38

45.82

6.3

6.1

e9/l

0.2

2.51

4033

33808

(3006315) Basophils [#/volume] in Blood

4448

37517

1.38

45.60

6.1

5.9

e9/l

0.0

1.37

3878

32200

(3031040) Bacteria [#/volume] in Urine by Automated count

5651

49676

1.39

44.18

5.1

4.6

e6/l

372.7

2045.7

4.85

663

(3023103) Potassium [Moles/volume] in Serum or Plasma

8194

77628

1.85

43.88

17.5

16.8

mmol/l

4.0

0.49

8001

75616

(3019550) Sodium [Moles/volume] in Serum or Plasma

8177

77428

1.83

43.71

17.4

16.7

mmol/l

139.7

0.29

7996

75559

(3001604) Monocytes [#/volume] in Blood

4412

37365

1.36

43.02

6.1

5.9

e9/l

0.6

2.88

3848

32064

(3048689) Calprotectin [Mass/mass] in Stool

1304

8874

1.55

42.53

2.3

2.2

ug/g

143.9

139.8

0.14

1027

6910

(3019198) Lymphocytes [#/volume] in Blood

4504

38354

1.36

41.94

6.2

5.9

e9/l

1.9

1.87

3964

33540

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1819

13400

1.45

40.01

1.3

iu/ml

32.2

36.3

0.57

572

4275

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7890

74242

1.63

39.81

5.1

4.5

mmol/l

4.7

4.85

7306

68414

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7795

73184

1.59

39.13

5.2

4.7

mmol/l

6.0

5.9

0.33

7123

66530

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8010

75728

1.67

38.77

5.6

5.1

mmol/l

2.8

2.17

7367

69451

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8309

79464

1.87

37.31

12.0

10.8

u/l

25.8

25.9

0.24

8040

76563

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7824

73695

1.57

36.69

5.0

4.5

mmol/l

1.5

2.93

7196

67526

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1711

12648

1.44

36.49

1.3

u/ml

14.5

13.8

0.09

640

4839

(3024731) MCV [Entitic volume]

8511

82189

2.22

35.41

23.4

21.5

91.1

91.2

0.76

8404

81002

(3007461) Platelets [#/volume] in Blood

8508

82154

2.21

35.31

23.5

21.5

e9/l

250.0

253.2

4.59

8307

79997

(40768797) Stomach Pathology biopsy report

1509

10956

1.46

35.30

1.3

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2957

24040

1.35

35.29

2.6

u/l

56.0

57.7

1.54

2699

22079

(3026361) Erythrocytes [#/volume] in Blood

8511

82197

2.21

35.26

23.5

21.5

e12/l

4.5

3.51

8287

79794

(3000963) Hemoglobin [Mass/volume] in Blood

8511

82212

2.21

34.99

23.6

21.6

g/l

135.3

134.5

5.70

8404

81042

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3828

32362

1.32

34.77

2.4

2.3

nmol/l

79.0

78.8

0.21

3423

28971

(3035941) MCH [Entitic mass]

8508

82186

2.19

34.74

23.4

21.4

30.3

0.61

8402

80997

(3010813) Leukocytes [#/volume] in Blood

8510

82213

2.20

34.74

23.5

21.6

e9/l

6.5

6.7

6.57

8280

79804

(3013650) Neutrophils [#/volume] in Blood by Automated count

4972

43644

1.32

34.39

8.9

9.3

e9/l

3.9

4.1

8.58

4388

38015

(3015171) Extractable nuclear Ab [Units/volume] in Serum

542

3103

1.80

34.27

1.3

u/ml

1.5

1.1

0.24

289

(3020564) Creatinine [Moles/volume] in Serum or Plasma

8280

79305

1.79

34.08

18.1

17.1

umol/l

75.0

75.8

1.58

8275

79280

(3035350) Ketones [Presence] in Urine by Test strip

4268

36741

1.31

33.62

4.1

3.8

estimate

0.0

1.08

760

6663

(3021601) Nitrite [Presence] in Urine by Test strip

4283

36919

1.31

33.28

5.5

5.1

estimate

0.0

0.22

777

6738

(3009261) Glucose [Presence] in Urine by Test strip

4318

37303

1.31

32.83

4.2

3.8

estimate

0.0

0.05

748

6632

(3006504) Eosinophils/100 leukocytes in Blood

4077

34984

1.31

32.40

6.4

6.1

3.0

2.8

5.39

3795

32472

(3022096) Basophils/100 leukocytes in Blood

3964

33966

1.30

31.49

6.5

6.2

0.7

3.19

3695

31554

(3019069) Monocytes/100 leukocytes in Blood

4089

35192

1.30

31.40

6.7

6.4

8.7

8.6

0.29

3819

32835

(3018010) Neutrophils/100 leukocytes in Blood

4123

35548

1.30

31.13

6.3

6.0

56.7

57.2

2.29

3837

33091

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7560

71139

1.46

30.95

4.5

4.0

mmol/l

1.3

0.49

6913

64632

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1652

12459

1.40

30.82

1.5

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3632

30818

1.30

30.80

2.9

2.8

ug/l

121.3

131.6

1.62

3334

28391

(3021960) Folate [Moles/volume] in Serum or Plasma

2235

17709

1.35

30.66

1.6

1.5

nmol/l

21.4

20.8

0.88

1913

15043

(3024561) Albumin [Mass/volume] in Serum or Plasma

3891

33346

1.30

30.52

4.7

4.8

g/l

35.8

35.5

4.20

3627

30883

(3002030) Lymphocytes/100 leukocytes in Blood

4164

36041

1.30

30.14

6.5

6.2

28.3

27.9

1.30

3866

33423

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4563

39995

1.29

29.87

5.7

6.3

umol/l

10.9

11.0

0.52

4320

37912

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4919

43599

1.29

29.26

2.8

2.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

403

2218

1.86

28.95

1.3

u/ml

13.9

42.6

2.14

134

(3005322) IgE [Units/volume] in Serum or Plasma

692

4426

1.61

28.90

1.3

u/ml

268.0

200.5

0.99

637

4055

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4436

38856

1.29

28.67

6.0

6.7

mmol/l

1.2

0.02

3756

32766

(3007853) Bacteria identified in Skin by Aerobe culture

1204

8691

1.45

28.49

1.8

—

(36660697) Celiac disease serology panel - Serum

858

5871

1.51

26.49

1.2

—

(42870588) Differential panel, method unspecified - Blood

3054

25809

1.28

25.10

6.3

5.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

4932

44176

1.27

24.91

4.4

4.6

mmol/l

6.7

1.00

4617

41347

(40761511) CBC panel - Blood by Automated count

8040

77098

1.52

24.78

15.0

13.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

364

2053

1.81

24.16

1.3

u/ml

2.9

6.1

2.34

326

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2253

18401

1.30

23.86

2.3

mg/l

2.9

3.0

1.73

1908

15760

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

357

2031

1.79

23.03

1.3

u/ml

6.0

4.3

0.34

207

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

305

1666

1.86

22.47

1.3

1.2

u/ml

4.9

4.6

0.03

120

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

304

1661

1.86

22.38

1.2

u/ml

0.4

14.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

302

1653

1.86

22.11

1.3

u/ml

44.0

46.4

0.10

181

(3000570) Elastase.pancreatic [Mass/mass] in Stool

398

2364

1.72

22.09

1.4

ug/g

274.7

277.6

0.10

233

1380

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5316

48408

1.25

21.65

3.4

3.1

u/l

47.4

49.3

0.83

4905

44845

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3991

35245

1.24

21.35

5.2

5.9

mmol/l

1.2

0.68

3583

31842

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2763

23417

1.26

21.24

2.1

u/l

159.0

208.8

3.79

2573

21889

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

160

705

2.29

21.13

1.3

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

372

2212

1.71

20.57

1.6

g/l

0.2

0.79

353

2086

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1259

9674

1.35

20.05

6.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2605

22060

1.26

19.85

2.8

2.9

ng/l

1103.4

1318.7

1.57

2192

18953

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

378

2283

1.69

19.74

1.6

g/l

1.2

0.03

360

2152

(4010399)

799

5712

1.44

19.54

1.5

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

468

2998

1.59

19.33

1.1

u/ml

1.4

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2141

17791

1.27

18.99

4.2

3.8

—

(3019150) Specific gravity of Urine by Refractometry

1942

15984

1.28

18.57

4.6

4.3

kg/l

1.0

0.14

289

2409

(3019309) Folate [Moles/volume] in Red Blood Cells

1758

14303

1.29

18.42

1.7

nmol/l

1158.8

1171.5

0.24

1308

10768

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1442

11431

1.31

18.38

1.5

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3293

28792

1.23

18.37

3.8

3.6

ng/l

118.4

61.1

0.40

2217

19860

(3044889) 12 lead EKG panel

5789

53644

1.23

18.17

4.1

3.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3217

28091

1.23

18.09

4.4

4.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7429

70917

1.31

17.80

14.2

13.6

ml/min/173m2

79.7

79.3

0.98

6231

58641

(3025941) Bacteria identified in Stool by Culture

596

4114

1.48

17.46

1.3

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

731

5264

1.42

17.12

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2820

24400

1.23

17.04

3.2

3.3

u/l

33.1

34.9

0.50

2649

23098

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

217

3.15

17.03

1.8

1.6

ug/l

9.5

8.7

0.82

217

(3015377) Calcium [Moles/volume] in Serum or Plasma

3040

26539

1.22

16.77

3.1

3.5

mmol/l

2.4

0.48

2607

23015

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

678

4838

1.44

16.69

1.2

iu/ml

133.6

147.6

0.47

254

1838

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2430

20763

1.24

16.40

1.7

1.6

mmol/l

1.4

0.20

2082

17306

(3020961) Endomysium IgA Ab [Titer] in Serum

489

3289

1.52

16.25

1.1

titre

126.3

199.0

0.44

(3029937) Albumin [Presence] in Urine by Test strip

2325

19791

1.24

16.22

4.6

4.3

estimate

0.0

0.03

760

6563

(3026008) Bacteria identified in Urine by Culture

2781

24127

1.22

16.16

3.5

3.2

—

(3012516) Albumin [Mass/volume] in Urine

2620

22678

1.22

15.40

3.4

3.2

mg/l

621.1

400.0

1.09

1575

13727

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

368

2355

1.59

15.30

1.6

1.8

—

(3032080) INR in Blood by Coagulation assay

3449

30704

1.20

15.08

8.6

8.7

inr

1.2

1.3

1.33

976

8643

(3009508) Creatinine [Moles/volume] in Urine

2719

23710

1.21

14.67

3.2

mmol/l

7.1

0.23

2280

19801

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1943

16381

1.24

14.55

1.7

pmol/l

79271074.0

31441717.8

1.57

1563

13495

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

608

4384

1.42

14.11

1.9

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2724

23833

1.21

14.05

4.1

3.9

mg/mmol

8.0

9.0

0.62

1640

14468

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

940

7275

1.33

13.97

2.2

g/l

0.2

0.50

867

6791

(3022145) Colonoscopy Study observation

1104

8744

1.30

13.88

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1960

16635

1.23

13.66

1.7

mg/l

1.1

1.2

1.28

1491

12773

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

669

4931

1.39

13.65

2.0

1.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

648

4756

1.39

13.56

1.3

au/ml

62.9

54.5

—

214

(3039162) Centromere protein B Ab [Units/volume] in Serum

182

1001

1.84

13.28

1.3

u/ml

49.8

64.2

0.38

(3017143) Hepatitis C virus Ab [Presence] in Serum

944

7363

1.32

13.26

1.5

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

889

6882

1.32

13.17

2.4

2.2

nmol/l

368.1

373.2

0.33

800

6302

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

577

4182

1.41

13.00

2.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

411

2798

1.49

12.92

1.6

—

(3042936) Bacteria identified in Isolate by Culture

1283

10450

1.27

12.86

2.0

—

(40761535) Cells panel - Urine sediment

818

6284

1.33

12.77

3.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

695

5219

1.36

12.62

2.5

2.4

au/ml

26.2

0.00

255

(3020717) Zinc [Moles/volume] in Serum or Plasma

364

2.35

12.18

1.3

1.4

umol/l

23.4

25.4

0.23

345

(3013512) EKG study

2567

22577

1.19

12.10

4.3

3.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

152

817

1.88

11.97

1.6

1.4

iu/ml

23.9

24.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

354

2384

1.51

11.76

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1883

16161

1.21

11.45

4.6

—

(3021589) Normoblasts [#/volume] in Blood

3635

33100

1.17

10.99

10.1

9.7

e9/l

0.0

0.53

3016

27012

(3018418) pH of Serum or Plasma

2630

23373

1.18

10.69

3.5

4.1

7.4

0.08

457

4408

(3022948) Iron [Moles/volume] in Serum or Plasma

1389

11640

1.23

10.64

2.4

2.5

umol/l

13.2

12.8

1.17

1280

10764

(3017446) Testosterone [Moles/volume] in Serum or Plasma

540

4009

1.37

10.55

2.2

nmol/l

12.5

12.7

0.17

473

3519

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

500

3667

1.39

10.53

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

583

4384

1.35

10.49

1.6

1.9

g/l

1.4

1.3

0.08

538

3980

(3005719) IgG [Mass/volume] in Serum or Plasma

726

5637

1.31

10.49

2.6

2.8

g/l

10.7

10.4

0.78

675

5152

(3026493) Urate [Moles/volume] in Serum or Plasma

2254

19805

1.19

10.44

2.6

umol/l

2432.5

4670.2

2.81

1937

17030

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2064

17998

1.19

10.43

5.0

4.9

ug/l

2.0

3.2

2.61

1845

16179

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

727

5652

1.31

10.41

1.6

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1735

14905

1.20

10.31

3.7

ng/l

348.9

440.9

0.39

1268

11694

(3018095) Leukocytes [#/volume] in Urine

2947

26512

1.17

10.17

3.9

3.7

e6/l

95.2

106.2

0.29

2105

18525

(3004588) Protein electrophoresis panel - Serum or Plasma

684

5298

1.32

10.06

2.2

2.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

111

572

1.95

10.00

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

111

572

1.95

10.00

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

111

573

1.95

9.95

1.2

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

2353

20823

1.18

9.92

3.2

3.1

e6/l

0.3

0.4

4.56

1774

15525

(40759836) Histone Ab [Presence] in Serum by Immunoblot

110

568

1.95

9.86

1.2

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

120

639

1.89

9.81

1.2

u/ml

46.2

56.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

110

569

1.95

9.81

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

110

569

1.95

9.81

1.2

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

289

1941

1.51

9.79

1.1

u/ml

8.0

7.3

0.07

203

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

117

619

1.90

9.76

1.2

u/ml

86.4

64.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3829

35217

1.15

9.71

4.1

4.0

—

(3004616) Nuclear Ab [Presence] in Serum

163

956

1.72

9.69

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1281

10748

1.22

9.63

2.4

2.5

g/l

2.4

2.3

1.37

1177

9945

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

117

622

1.89

9.62

1.2

u/ml

59.8

29.8

0.87

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1515

12929

1.21

9.59

2.8

2.7

e6/l

0.8

1.5

2.25

883

7296

(3002582) Erythrocytes [#/volume] in Urine

2526

22543

1.17

9.51

3.3

3.2

e6/l

44.5

70.8

2.07

1939

17125

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

254

2.41

9.40

1.8

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

6936

66784

1.18

9.16

16.8

15.7

39.9

39.5

3.23

4606

46829

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

814

6534

1.27

9.09

2.6

2.8

ng/l

173.9

183.4

0.23

739

5953

(3009445) Proteinase 3 Ab [Units/volume] in Serum

443

3274

1.37

8.94

1.4

1.6

u/ml

7.3

16.6

—

(3019225) pH of Specimen

961

7914

1.24

8.59

4.2

4.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

109

592

1.85

8.45

1.2

u/ml

2.2

3.9

—

(3034770) Mitochondria Ab [Titer] in Serum

299

2095

1.44

8.23

1.3

1.2

titre

1147.5

895.1

0.33

(46235355) HIV 1 and 2 tests - Meaningful Use set

1172

9911

1.21

8.07

1.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

355

2576

1.39

8.04

1.6

titre

409.2

285.3

0.27

119

(3007566) Smooth muscle Ab [Titer] in Serum

298

2099

1.43

7.99

1.2

titre

102.2

141.8

0.50

189

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

367

2683

1.38

7.95

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1397

12033

1.19

7.87

1.8

1.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

781

6352

1.25

7.80

2.4

2.6

g/l

67.2

66.4

2.44

712

5756

(3008898) HLA-B27 [Presence]

316

2268

1.41

7.64

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1659

14538

1.17

7.61

2.8

3.0

mmol/l

2.5

1.47

1455

12725

(3000850) Epithelial cells [#/volume] in Urine

1774

15639

1.17

7.54

2.6

e6/l

5.0

6.0

2.42

1529

13672

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

356

2615

1.38

7.51

1.9

1.8

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

291

2066

1.42

7.49

1.3

1.5

iu/ml

25.4

15.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

291

2066

1.42

7.49

1.8

1.7

—

(3025130) Human papilloma virus identified in Specimen

153

953

1.62

7.34

1.8

1.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1156

9851

1.20

7.31

23.3

24.3

inr

1.3

0.97

191

1436

(36304419) Bacteria [Presence] in Urine

2251

20243

1.15

7.29

3.2

3.1

—

(40758558) Short blood count panel - Blood

2169

19464

1.15

7.23

6.5

6.9

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

478

1.87

7.21

1.1

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1372

11893

1.18

7.14

3.0

2.9

e6/l

2.7

3.0

0.56

748

6308

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

474

1.87

7.07

1.1

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2162

19423

1.15

7.07

3.7

3.5

—

(3045414) Leukocytes [Presence] in Urine

459

3539

1.31

7.03

2.0

1.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1175

10067

1.19

6.99

2.4

2.6

22.7

22.2

0.55

966

8536

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1018

8608

1.21

6.99

1.5

1.6

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

3.49

6.97

1.0

1.2

u/ml

1.2

0.0

0.48

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

370

2773

1.35

6.90

2.4

2.3

g/l

9.9

10.1

0.54

301

2322

(3010144) Erythrocytes [#/volume] in Synovial fluid

119

708

1.69

6.85

1.5

1.4

e6/l

37766.5

107146.5

1.49

476

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

778

6444

1.23

6.58

2.2

2.3

ug/l

5.9

7.3

1.42

658

5609

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1626

14377

1.16

6.56

4.4

4.2

21.6

21.8

0.30

708

6960

(44813793)

495

1.81

6.50

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

6354

61242

1.14

6.47

18.6

17.8

13.7

1.58

6232

59949

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

170

1120

1.53

6.45

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

944

8008

1.20

6.25

1.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

297

2186

1.37

6.25

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

159

1043

1.53

6.17

1.3

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

295

2177

1.37

6.12

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

300

2221

1.36

6.10

1.5

—

(3026782) Osmolality of Urine

1630

14487

1.15

6.09

2.9

2.8

mosm/kgh2o

524.7

533.5

0.92

1358

12321

(3017732) Neutrophils [#/volume] in Blood

642

5262

1.24

6.01

2.7

3.0

e9/l

4.0

4.1

0.33

471

4014

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.16

6.00

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1123

9709

1.18

5.99

5.1

4.6

32.3

32.8

0.69

743

6462

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

386

2977

1.31

5.95

2.4

2.3

g/l

7.4

7.5

0.35

288

2218

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

164

1093

1.51

5.93

1.7

1.9

pmol/l

190.8

200.9

0.65

156

1031

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

385

2970

1.31

5.93

2.4

2.3

g/l

3.8

0.07

281

2112

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

385

2973

1.31

5.89

2.4

2.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

244

1757

1.40

5.89

1.3

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

363

2788

1.32

5.78

2.4

2.3

g/l

2.9

3.1

2.25

283

2161

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

290

2155

1.36

5.78

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

377

1.86

5.71

1.4

1.6

ug/l

6.5

9.0

1.73

338

(3025159) Blasts/100 leukocytes in Blood

697

5803

1.22

5.62

3.9

4.2

0.1

0.4

1.78

156

1447

(3004716) Salmonella sp identified in Stool by Organism specific culture

432

3418

1.28

5.51

1.3

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

114

713

1.61

5.49

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

390

3051

1.29

5.44

5.0

5.2

0.9

0.08

369

2862

(3003338) MCHC [Mass/volume]

6421

62150

1.12

5.41

20.4

18.9

g/l

332.4

331.7

6.48

6382

61733

(3024980) IgG subclass 4 [Mass/volume] in Serum

174

1200

1.46

5.36

1.8

1.6

g/l

0.6

0.7

1.24

132

891

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

152

1021

1.50

5.34

1.3

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

392

3080

1.29

5.29

4.9

5.2

1.7

1.6

0.34

371

2884

(3025468) Yersinia sp identified in Specimen by Organism specific culture

151

1016

1.49

5.27

1.3

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

704

5907

1.21

5.26

3.8

4.0

0.7

0.6

0.52

145

1337

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

412

3261

1.28

5.25

2.1

1.9

u/l

40.2

39.2

0.41

353

2865

(4062490)

119

762

1.57

5.21

1.7

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

143

954

1.51

5.20

1.7

1.6

60.0

57.5

0.30

584

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

977

8448

1.18

5.20

4.0

4.3

u/l

231.2

245.5

3.88

910

7973

(3023520) Reticulocytes [#/volume] in Blood

733

6181

1.20

5.20

2.6

e9/l

71.0

70.2

0.24

563

4649

(3005988) Vibrio sp identified in Specimen by Organism specific culture

151

1020

1.49

5.18

1.3

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

254

1884

1.36

5.17

1.7

1.6

e6/l

13625.3

12492.5

0.18

181

1353

(3024522) Salmonella sp identified in Specimen by Organism specific culture

152

1029

1.49

5.16

1.3

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

276

2077

1.34

5.11

1.5

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

959

8297

1.17

5.07

1.7

1.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

150

1017

1.48

5.06

1.3

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

957

8281

1.17

5.05

1.8

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

272

2050

1.34

4.99

2.2

2.0

mg/l

10.4

11.4

1.33

248

1890

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

160

2.26

4.96

3.1

2.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

568

4701

1.22

4.89

5.8

7.0

mmol/l

24.4

24.7

0.99

529

4374

(3000492) Spirometry study

818

7015

1.18

4.81

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

197

1420

1.40

4.80

1.3

u/l

11.3

12.3

0.47

160

1144

(3047181) Lactate [Moles/volume] in Blood

308

2380

1.30

4.76

5.4

6.1

mmol/l

1.3

0.01

277

2101

(3017181) Myelocytes/100 leukocytes in Blood

761

6493

1.19

4.75

4.0

4.1

1.0

0.9

0.30

186

1864

(3024139) IgG subclass 3 [Mass/volume] in Serum

117

764

1.54

4.74

1.7

1.4

g/l

0.4

0.80

523

(3028192) IgG subclass 2 [Mass/volume] in Serum

117

764

1.54

4.74

1.7

1.4

g/l

3.1

2.8

0.62

522

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

581

4846

1.21

4.64

3.2

3.3

pmol/l

4.4

0.69

507

4284

(3027945) Reticulocytes/100 erythrocytes in Blood

940

8180

1.17

4.62

2.5

1.8

0.33

830

7249

(3012494) Peanut IgE Ab [Units/volume] in Serum

159

2.21

4.60

1.1

u/ml

1.5

1.3

0.06

(3027135) IgG subclass 1 [Mass/volume] in Serum

116

764

1.53

4.54

1.7

1.4

g/l

6.7

6.8

0.15

522

(3021440) Promyelocytes/100 leukocytes in Blood

724

6177

1.19

4.53

4.0

4.2

0.1

0.10

177

1730

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

918

7991

1.17

4.50

1.7

1.5

0.62

810

6946

(3019832) Treponema pallidum Ab [Presence] in Serum

486

4002

1.23

4.42

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

288

2231

1.30

4.40

1.6

iu/ml

0.2

4.5

0.90

488

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

298

2327

1.29

4.29

2.2

g/l

38.5

37.7

1.49

255

1984

(3023368) Bacteria identified in Blood by Culture

2170

20022

1.11

4.28

4.2

4.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

631

5353

1.19

4.23

1.4

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

997

8781

1.15

4.18

2.3

2.7

umol/l

6.9

8.2

1.85

855

7604

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1393

12564

1.13

4.08

2.9

3.2

mmol/l

0.8

0.13

1291

11715

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

142

999

1.43

4.04

1.8

2.1

mg/l

32.7

25.0

0.73

256

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

268

1.83

3.93

1.2

1.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

206

1.95

3.85

2.0

1.9

mg/l

9.2

9.4

0.07

165

(3033923) Metanephrine [Moles/time] in 24 hour Urine

173

2.03

3.78

1.0

1.2

umol/24h

0.6

0.7

0.33

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.53

3.76

1.0

1.7

—

(3022621) pH of Urine by Test strip

590

5034

1.18

3.73

3.2

3.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

454

3784

1.21

3.72

2.7

e6/l

0.3

0.30

437

3682

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

239

1.85

3.63

1.3

1.2

g/l

0.3

0.13

190

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

714

6204

1.16

3.62

2.5

2.7

ml/min/173m2

65.3

64.6

0.23

300

2459

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1085

9711

1.13

3.60

5.0

5.7

mmol/l

1.0

2.98

1014

9032

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

246

1927

1.28

3.53

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

316

2556

1.25

3.47

1.4

1.3

iu/l

29.5

35.1

2.49

283

2194

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

567

1.52

3.45

1.1

1.0

mg/l

284.2

290.1

0.33

505

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

262

2077

1.27

3.43

2.3

g/l

0.0

0.34

244

1884

(3019060) Gas panel - Arterial blood

577

4955

1.18

3.41

4.3

4.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

609

1.50

3.41

1.3

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

257

2041

1.27

3.32

2.4

2.3

g/l

0.0

0.00

240

1880

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

454

1.57

3.28

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

232

1827

1.28

3.23

1.2

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

456

1.56

3.22

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

103

2.24

3.21

1.2

—

95.3

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.16

3.21

1.8

1.4

mg/l

0.1

0.8

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.16

3.21

1.8

1.4

mg/l

1.2

2.4

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.16

3.21

1.8

1.4

mg/l

4.3

0.7

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.16

3.21

1.8

1.4

mg/l

0.6

2.0

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.16

3.21

1.8

1.4

mg/l

5.8

2.0

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.16

3.21

1.8

1.4

mg/l

2.5

3.6

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.16

3.21

1.8

1.4

mg/l

1.0

3.4

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.16

3.21

1.8

1.4

mg/l

0.4

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

497

1.53

3.19

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

343

2833

1.22

3.13

1.9

1.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

276

2229

1.25

3.11

2.3

g/l

0.0

0.02

257

2031

(3029075) Extractable nuclear Ab panel - Serum

208

1.83

3.11

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

406

1.58

3.08

1.3

1.2

—

(3021788) Differential panel - Synovial fluid

185

1428

1.30

3.03

1.7

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

217

1712

1.27

3.00

1.8

1.7

mu/l

287.2

303.4

0.42

198

1546

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

594

1.47

3.00

1.3

1.2

titre

198.0

143.2

0.28

111

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

516

1.50

2.92

1.9

2.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

369

3094

1.20

2.91

2.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

308

2539

1.22

2.89

2.3

2.4

g/l

1.0

0.8

0.34

269

2171

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

297

1.65

2.85

3.5

2.7

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

171

1.87

2.84

2.5

1.9

ug/l

1.4

2.3

2.22

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

200

1.80

2.84

1.3

36.1

35.4

0.04

132

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

135

1007

1.35

2.83

1.1

—

(3039000) Anion gap in Blood

214

1701

1.26

2.81

6.4

7.1

mmol/l

11.2

0.04

195

1528

(3018572) Chloride [Moles/volume] in Blood

214

1702

1.26

2.80

6.4

7.1

mmol/l

105.3

105.0

0.30

195

1529

(3000093) Morphology [Interpretation] in Blood Narrative

679

1.42

2.78

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.43

2.70

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

119

879

1.36

2.68

1.1

u/ml

1.7

1.9

0.06

192

(3002173) Hemoglobin [Mass/volume] in Arterial blood

793

7102

1.13

2.65

7.0

7.9

g/l

121.6

120.6

0.74

761

6841

(3047007) Chlamydophila sp Ab [Presence] in Serum

130

977

1.34

2.62

1.3

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

336

1.58

2.61

1.1

1.0

u/ml

14.5

1.7

0.42

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

705

1.39

2.60

1.5

26.8

31.1

0.56

411

(3023430) Cat dander IgE Ab [Units/volume] in Serum

714

1.39

2.59

1.1

1.0

u/ml

5.4

3.4

0.34

255

(3016502) Oxygen saturation in Arterial blood

851

7668

1.12

2.57

6.6

7.5

96.3

95.7

3.49

815

7376

(3017704) Immunofixation for Urine

401

1.52

2.57

1.8

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

152

1172

1.30

2.56

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

490

4259

1.16

2.56

1.4

1.5

—

(3044941) Cell count panel - Synovial fluid

156

1208

1.30

2.55

1.4

—

(3001218) Citrate [Mass/time] in 24 hour Urine

7.14

2.55

1.6

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

362

1.55

2.55

2.6

2.7

—

31.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

323

1.58

2.53

1.0

u/ml

6.3

0.5

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

107

785

1.37

2.53

1.2

1.1

—

2.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

684

6092

1.13

2.51

3.1

3.6

ng/l

85.6

89.4

0.51

576

5189

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

239

1954

1.23

2.48

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

470

1.47

2.47

1.3

1.6

u/l

5.1

6.5

1.71

394

(3014133) Dog dander IgE Ab [Units/volume] in Serum

104

763

1.37

2.47

1.1

u/ml

1.0

3.5

3.62

272

(3011412) CD3 cells [#/volume] in Blood

704

1.38

2.46

2.1

2.3

e9/l

1.2

1.1

0.22

416

(3045716) Anion gap in Serum or Plasma

342

1.55

2.44

2.4

mmol/l

8.4

9.3

1.36

257

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.55

2.44

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

546

1.43

2.43

1.9

2.0

15.2

14.6

0.13

223

(3049717) Cytology report of Urine Cyto stain

314

2644

1.19

2.42

2.4

2.6

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

103

2.04

2.41

1.0

ug/l

91.4

79.0

0.50

(3027696) Helicobacter pylori Ab [Titer] in Serum

6.25

2.37

1.0

1.1

titre

1076.0

1477.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

450

1.47

2.37

1.1

iu/ml

4.4

10.8

2.73

109

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.61

2.35

1.1

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

169

1339

1.27

2.34

1.1

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

542

4780

1.14

2.33

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

722

1.36

2.29

3.8

3.6

—

(3003396) Base excess in Arterial blood by calculation

940

8580

1.11

2.27

6.4

7.1

mmol/l

1.0

1.1

0.25

723

6760

(3052592) Norovirus Ag [Presence] in Stool

149

1.81

2.23

1.1

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

114

864

1.32

2.22

1.4

u/l

37.1

32.7

0.61

693

(3052851) Hemolysis interference index of Serum or Plasma

278

2337

1.20

2.22

2.7

3.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

155

1225

1.27

2.21

1.8

1.4

—

(3007919) Fasciola sp Ab [Titer] in Serum

5.56

2.21

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

218

1.65

2.17

1.2

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

542

1.41

2.17

1.8

1.7

umol/l

10.8

8.5

0.37

382

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

122

1.89

2.15

1.1

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

221

1827

1.22

2.12

2.4

2.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

412

1.46

2.11

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

463

4073

1.14

2.10

8.2

9.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

213

1.65

2.09

1.6

ug/l

0.5

0.4

0.90

137

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.14

2.08

1.1

1.0

u/ml

0.5

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

399

3478

1.15

2.06

3.6

3.4

mmol/l

25.3

0.09

388

3386

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.98

2.04

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

199

1.66

2.04

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

533

1.39

2.02

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

383

1.47

2.02

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

129

1010

1.28

2.01

1.1

g/l

1.5

0.79

118

901

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

593

1.37

2.01

1.4

1.7

—

(3000330) Specific gravity of Urine by Test strip

443

3899

1.14

2.01

4.4

3.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

536

1.38

1.97

1.2

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

203

1679

1.21

1.96

2.6

2.2

g/l

130.4

128.2

0.60

144

1179

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

345

1.48

1.96

1.4

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

461

1.41

1.95

2.2

2.6

e9/l

0.2

0.03

396

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

935

8601

1.10

1.95

6.4

7.1

kpa

5.1

0.28

886

8213

(3044927) Protein electrophoresis panel - Urine

103

787

1.31

1.94

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.96

1.93

1.0

—

(4038314)

3.75

1.93

1.5

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

371

1.46

1.92

1.0

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

712

6467

1.11

1.92

6.0

7.4

mmol/l

8.8

9.8

3.52

669

6177

(3043410) Blood group antigens tested for on Red Blood Cells

195

1.64

1.92

1.3

1.8

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

258

1.55

1.91

1.4

1.3

umol/l

3.7

0.01

240

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

193

1593

1.22

1.91

1.2

1.3

mmol/l

3.8

0.20

180

1496

(4281824)

1026

0.74

1.90

1.2

—

(3037121) Protein [Mass/volume] in Urine

300

2578

1.17

1.90

2.5

3.0

g/l

0.4

0.3

0.83

118

999

(3028679) Herpes simplex virus Ab [Presence] in Serum

323

1.49

1.90

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

158

1.71

1.88

1.0

—

(3027801) Oxygen [Partial pressure] in Arterial blood

933

8600

1.09

1.87

6.4

7.1

kpa

12.6

12.4

0.53

885

8210

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

114

1.84

1.86

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

525

1.37

1.86

1.2

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

127

1006

1.27

1.84

1.0

1.1

u/ml

5.6

4.1

0.38

474

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

629

1.34

1.84

1.1

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

484

1.39

1.83

2.1

2.5

e6/l

469.6

511.2

0.36

402

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.50

1.83

1.1

1.3

—

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

4.17

1.82

1.0

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

102

789

1.30

1.79

3.6

58.3

57.6

0.14

506

(3016650) Hepatitis A virus Ab [Presence] in Serum

142

1147

1.24

1.75

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

396

1.42

1.74

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1232

11531

1.08

1.73

1.9

2.1

29.7

0.14

1188

11188

(4094501)

246

2099

1.18

1.73

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

731

0.71

1.71

1.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.38

1.67

1.0

1.1

u/ml

0.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

104

815

1.28

1.67

3.9

4.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

145

1182

1.23

1.66

1.6

1.7

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.16

1.66

1.2

1.7

3.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

667

1.31

1.65

1.3

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

503

1.35

1.64

1.3

u/ml

0.7

1.0

0.25

250

(1002224) Polysomnography panel

321

2811

1.15

1.62

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

205

1.56

1.61

3.3

2.9

mg/l

7.7

7.8

0.02

165

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

403

1.39

1.60

2.3

2.9

38.7

38.9

0.03

143

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.87

1.60

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

190

1602

1.19

1.56

1.3

1.4

e6/l

22.8

33.4

0.35

140

1244

(3045424) Erythrocytes [Presence] in Urine

160

1329

1.21

1.55

1.4

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

190

1604

1.19

1.54

1.4

e6/l

838.4

1448.7

0.74

151

1307

(3012544) pH of Venous blood

753

6942

1.09

1.54

3.5

3.8

7.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

107

1.78

1.54

1.2

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

145

1.66

1.53

1.1

1.3

mg/l

0.5

48.0

0.73

106

(3038177) Helicobacter pylori Ab [Presence] in Serum

142

1167

1.22

1.53

1.3

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

373

1.40

1.53

1.6

1.5

3.1

3.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

532

5856

0.90

1.53

1.7

1.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

223

1911

1.17

1.52

5.4

4.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

298

1.45

1.52

2.1

2.2

ug/l

25.1

213.2

0.93

277

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

213

1819

1.18

1.52

1.3

mg/l

506.7

551.3

0.77

201

1727

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

781

7221

1.09

1.51

2.4

u/l

40.2

44.2

0.17

659

6155

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.86

1.50

1.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

590

1.31

1.49

1.9

2.2

49.5

41.6

0.82

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

176

1481

1.19

1.49

1.6

—

(3021901) Oxygen saturation in Capillary blood

154

1280

1.21

1.49

3.0

2.8

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

540

1.32

1.46

1.3

1.4

mmol/l

2.0

2.1

1.08

508

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

343

1.40

1.45

1.2

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.13

1.44

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

157

1.59

1.40

1.7

1.6

ng/l

112.4

112.8

0.01

157

(3045683) HLA typing for celiac disease panel - Blood or Tissue

397

1.36

1.40

1.1

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

205

1.51

1.39

1.0

1.1

84.0

89.5

0.33

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

135

1117

1.21

1.39

1.1

u/ml

2.5

1.4

0.39

412

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

378

3386

1.12

1.39

1.7

1.6

g/l

1.5

1.6

1.87

323

2905

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.08

1.38

1.0

u/ml

0.6

0.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1916

18340

1.06

1.38

2.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

280

1.43

1.37

1.6

1.5

pmol/l

15.2

15.9

0.40

236

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

290

2559

1.14

1.36

2.4

2.3

ug/l

237.4

607.7

3.12

272

2408

(3009466) Valproate [Moles/volume] in Serum or Plasma

1015

0.79

1.36

3.1

5.1

umol/l

350.6

363.6

0.30

875

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

343

3836

0.89

1.35

1.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

1.34

0.0

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

1.34

0.0

3.4

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

1.32

0.0

12.7

—

371.3

—

(40768441) Liver Pathology biopsy report

567

1.29

1.32

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

1.31

0.0

4.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

118

971

1.22

1.30

1.0

1.1

u/ml

1.3

1.2

0.10

376

(21494434) Karyotype in Bone marrow

648

1.27

1.30

1.1

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

490

4472

1.10

1.29

1.8

1.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

185

1.52

1.28

1.3

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

352

1.37

1.28

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.08

1.27

1.1

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.00

1.27

1.1

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

202

1.49

1.26

1.0

1.2

89.4

89.2

0.01

101

(3042517) Benzodiazepines panel - Urine

2.05

1.26

1.2

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

353

1.36

1.26

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

353

1.36

1.26

1.5

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

177

1517

1.17

1.26

2.9

2.8

kpa

8.1

0.17

161

1402

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

494

4518

1.10

1.25

3.3

3.5

kpa

5.1

5.2

1.00

449

4174

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

154

1.56

1.25

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

397

1.34

1.25

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

397

1.34

1.25

1.3

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.86

1.23

2.5

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

205

1782

1.15

1.22

2.9

3.1

mmol/l

24.5

25.0

0.97

171

1550

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

207

1801

1.15

1.22

1.5

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

203

1764

1.15

1.22

1.3

miu/ml

215.2

215.3

0.00

786

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.80

1.21

1.0

1.2

umol/24h

1.7

0.02

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

593

1.27

1.20

1.3

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1097

10375

1.07

1.20

3.0

ug/l

0.7

0.8

0.03

693

6890

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

648

1.25

1.18

1.0

u/ml

0.5

0.02

135

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.11

1.18

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.11

1.18

1.0

1.7

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

165

1.52

1.17

1.4

g/l

24.1

26.4

0.29

128

(3023419) Bacteria identified in Sputum by Culture

114

949

1.20

1.15

2.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

179

1550

1.16

1.14

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

179

1550

1.16

1.14

1.3

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

1.14

0.0

1.0

—

112.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

482

4428

1.09

1.13

3.4

3.3

g/l

128.6

128.3

0.10

471

4322

(3033658) Prothrombin time (PT) actual/Normal

2014

19404

1.05

1.13

3.8

3.9

92.3

91.2

1.09

1947

18926

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.69

1.13

1.0

1.4

nmol/l

4.3

413931.8

0.91

(3014576) Chloride [Moles/volume] in Serum or Plasma

995

9403

1.07

1.12

6.2

6.9

mmol/l

104.5

104.3

0.71

972

9192

(3036048) Francisella tularensis Ab [Titer] in Serum

159

1.51

1.11

1.0

1.1

—

253.3

—

(3010503) CD19 cells [#/volume] in Blood

468

1.28

1.09

2.4

2.5

e9/l

0.2

0.4

0.75

451

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

275

2461

1.12

1.09

3.2

3.4

mg/l

48.6

48.3

0.01

230

1994

(3034860) Kappa light chains.free [Mass/volume] in Serum

275

2461

1.12

1.09

3.2

3.4

mg/l

44.2

76.2

0.75

227

1992

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

407

1.30

1.08

1.1

—

(3009343) pH of Capillary blood

484

4459

1.09

1.08

3.4

3.5

7.4

0.54

568

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

244

2169

1.13

1.08

1.7

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

244

2171

1.13

1.07

1.8

1.7

—

(3022689) Creatine [Moles/volume] in Urine

228

1.40

1.05

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

795

1.21

1.05

1.2

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

712

6674

1.07

1.04

3.4

3.8

kpa

5.8

0.35

696

6494

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

267

2394

1.12

1.03

3.2

3.3

ratio

2.5

1.9

0.22

189

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.27

1.03

1.2

1.5

nmol/l

562.9

531.4

—

(40761536) Microorganisms panel - Urine sediment

672

6288

1.07

1.03

4.4

4.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

150

0.53

1.02

1.5

1.8

mmol/l

1.2

—

145

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

465

4291

1.09

1.02

3.3

3.4

mmol/l

1.5

1.8

1.29

348

3235

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

181

1586

1.14

1.01

1.6

1.5

—

(3006270) Folate [Moles/volume] in Blood

644

1.23

1.01

1.1

nmol/l

395.0

355.5

0.75

551

(40765096) Chromosome analysis panel by Banding

213

1.41

1.01

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

110

927

1.19

1.01

1.1

u/ml

2.9

3.4

0.25

397

(3001686) Cold agglutinin [Titer] in Serum or Plasma

147

1.50

1.00

1.3

1.4

—

196.0

—

(4034850)

273

2457

1.11

1.00

10.6

9.7

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

103

864

1.19

1.00

2.4

2.9

13.4

13.2

0.73

103

851

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.17

0.98

1.0

—

(3036603) Volume of Urine

521

1.25

0.98

1.4

1.6

1496.5

1834.1

0.80

130

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

283

1.34

0.98

1.2

1.1

miu/ml

1512.1

1542.7

0.06

283

(21494814) CD8 cells/100 lymphocytes in Specimen

309

1.33

0.98

2.1

1.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

104

1231

0.84

0.97

1.3

1.2

u/ml

281.1

287.0

0.08

774

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.97

0.0

1.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.95

0.97

2.1

1.7

—

0.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

301

1.33

0.96

1.1

ng/l

86.0

349.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.80

0.96

1.7

2.1

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

0.96

0.0

5.0

—

16.9

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

731

1.21

0.95

1.1

—

79.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

695

1.21

0.95

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

134

1156

1.16

0.94

1.3

1.4

—

(3020891) Body temperature

329

3002

1.10

0.94

3.6

4.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

153

1334

1.15

0.94

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

101

1.59

0.93

1.0

1.1

—

(4015189)

217

1.38

0.93

3.1

2.2

—

(3019977) pH of Arterial blood

427

1.27

0.92

2.1

2.9

7.4

0.81

145

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

107

909

1.18

0.92

1.2

u/l

60.4

62.0

0.09

617

(3004451) EKG impression Narrative

374

1.28

0.92

1.4

1.3

—

(3020491) Glucose [Moles/volume] in Blood

526

1.24

0.91

1.5

1.9

mmol/l

6.9

6.8

0.04

355

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

124

1437

0.86

0.91

1.5

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.14

0.91

1.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

252

2274

1.11

0.90

3.3

4.2

mmol/l

3.8

3.9

0.18

240

2133

(3028707) Methadone [Presence] in Urine by Screen method

755

1.19

0.89

1.9

2.9

—

(21494890) Protein electrophoresis panel - 24 hour Urine

792

1.19

0.89

1.8

2.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

291

2648

1.10

0.89

3.1

4.0

mmol/l

1.4

1.3

0.18

286

2603

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

829

1.18

0.89

1.6

—

(3037756) Immunofixation for Serum or Plasma

181

1604

1.13

0.89

1.8

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

113

1315

0.86

0.89

1.3

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

245

1.35

0.88

1.2

g/l

39.2

38.7

0.05

131

(3023410) Appearance of Cerebral spinal fluid

729

1.20

0.88

1.3

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

457

1.25

0.88

1.1

nmol/l

1.0

9.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

111

951

1.17

0.87

1.2

mmol/l

7.7

7.4

0.25

707

(3002032) Base excess in Venous blood by calculation

707

6675

1.06

0.87

3.4

3.8

mmol/l

1.9

2.0

0.47

581

5466

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

121

1045

1.16

0.86

1.4

1.3

nmol/l

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.72

0.86

1.8

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

396

1.26

0.86

1.7

1.4

nmol/l

1.4

1.2

0.66

305

(3035637) Corticotropin [Mass/volume] in Plasma

109

935

1.17

0.85

1.6

1.5

—

(3002256) Pathology report gross observation

1055

10087

1.05

0.84

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

213

1.36

0.84

1.3

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

142

1616

0.88

0.83

4.3

3.5

mg/l

19.2

27.1

2.72

992

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

301

1.30

0.82

1.1

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

169

1501

1.13

0.82

3.3

2.8

umol/l

33.0

33.9

0.20

143

1291

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

408

1.25

0.81

1.3

1.1

ratio

1.1

0.46

145

(3016228) CD19 cells/100 cells in Blood

319

1.29

0.81

2.1

1.9

7.7

8.5

0.16

309

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

214

1929

1.11

0.81

1.8

iu/l

4.9

9.3

0.47

688

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

293

1.30

0.81

1.9

2.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

145

1277

1.14

0.80

1.7

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.70

0.80

1.3

1.8

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

747

1.18

0.79

1.7

titre

10416.0

1084.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

191

1715

1.12

0.78

1.6

—

(3042733) HLA Ab [Presence] in Serum

223

0.67

0.78

4.0

4.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

607

0.81

0.78

1.7

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.77

0.0

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

682

0.82

0.76

2.6

2.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

252

1.31

0.76

1.9

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.76

0.0

5.5

—

393.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

193

1738

1.11

0.76

1.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

341

1.26

0.75

5.3

5.0

u/ml

1794.7

582.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

919

0.85

0.75

1.3

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

297

1.28

0.75

1.4

5.1

mg/l

70.9

749.3

0.48

211

(40761539) Cells [Type] in Urine sediment by Light microscopy

192

1.36

0.74

1.2

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

342

1.26

0.74

1.7

1.6

nmol/l

5.8

5.2

0.08

277

(3000012) Reticulocyte production index

396

1.24

0.74

1.4

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

698

1.18

0.73

1.4

1.6

—

(3017569) Oxygen content in Arterial blood

352

1.25

0.72

1.5

2.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

146

1298

1.13

0.72

1.6

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

616

1.19

0.72

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.52

0.72

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

207

1878

1.10

0.72

2.2

2.9

mg/l

1.5

1.6

0.93

187

1720

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

425

1.22

0.71

1.3

1.5

—

(3003181) Sodium [Moles/volume] in Urine

155

1385

1.12

0.71

1.4

mmol/l

59.0

62.9

0.65

121

1104

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

206

0.68

0.71

1.9

1.8

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

151

1.39

0.71

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

275

0.73

0.70

1.1

—

(4146454)

841

1.16

0.70

3.1

2.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

823

7867

1.05

0.69

3.1

3.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

805

1.16

0.69

3.3

13.4

mmol/l

7.6

7.5

0.03

665

(3044290) Cell count panel - Cerebral spinal fluid

165

1484

1.11

0.68

1.2

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

110

1.46

0.68

1.0

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

401

1.22

0.67

1.6

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

401

1.22

0.67

1.6

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

401

1.22

0.67

1.6

2.0

—

(3044640) Blood type and Crossmatch panel - Blood

2464

24088

1.03

0.67

2.3

2.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

420

1.22

0.66

1.3

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

402

1.22

0.66

1.6

2.0

—

(3045788) Cell count panel - Pleural fluid

658

0.83

0.65

1.7

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

476

1.20

0.65

1.3

1.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

133

1186

1.12

0.65

1.4

1.3

nmol/l

0.6

2.0

0.69

126

1140

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

120

1.42

0.64

10.6

7.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

504

0.81

0.64

1.2

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

839

1.15

0.64

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

138

1235

1.12

0.64

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

112

990

1.13

0.63

4.2

6.8

mg/l

11.1

11.9

1.03

101

910

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

115

1019

1.13

0.63

1.4

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

104

1.44

0.62

1.2

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

164

1.34

0.62

1.4

2.1

e6/l

164.6

148.3

0.17

(3032868) Hemoglobin electrophoresis panel in Blood

1.59

0.61

1.6

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.46

0.61

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.60

0.61

1.1

u/l

—

4.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

191

1.31

0.60

1.2

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

813

0.86

0.60

1.5

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.60

0.0

1.0

—

11360.5

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

0.00

0.60

0.0

1.0

—

0.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

272

2527

1.08

0.59

1.9

1.7

mg/l

4.8

3.6

0.71

200

1814

(4035726)

755

7237

1.05

0.59

1.4

—

(40768446) Kidney Pathology biopsy report

266

0.75

0.59

1.4

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

680

6503

1.05

0.59

3.4

3.9

mmol/l

1.2

0.13

605

5672

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

761

1.14

0.59

1.1

—

4.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

949

0.87

0.58

1.6

1.5

g/l

34.3

32.8

0.46

856

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

220

0.73

0.58

1.2

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.58

0.0

1.1

—

17.7

—

(44806071)

1.46

0.57

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

115

0.61

0.57

1.0

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

428

1.19

0.57

1.1

u/l

15.9

25.2

1.70

318

(3028308) Erythrocytes [#/volume] in Pleural fluid

755

0.86

0.57

1.6

1.4

e6/l

72143.0

55857.6

0.16

438

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

302

2824

1.07

0.56

3.5

3.7

mmol/l

24.7

25.0

0.86

282

2588

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

273

2544

1.08

0.56

2.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

411

1.19

0.56

1.1

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

572

5459

1.05

0.55

2.9

3.1

kpa

4.5

4.6

0.44

555

5293

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

240

2229

1.08

0.54

1.2

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

142

1.34

0.54

1.5

1.3

—

(40767503) Oxygen content in Capillary blood by calculation

172

1576

1.09

0.54

2.9

2.5

16.1

16.2

0.09

791

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

137

1510

0.91

0.54

2.5

2.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

654

0.86

0.53

1.3

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.48

0.53

1.1

u/l

6.3

15.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.48

0.53

4.3

6.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

149

1357

1.10

0.53

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

497

1.17

0.53

2.3

2.6

e6/l

775.9

679.3

0.37

218

(40758358) Immune stain study

1.54

0.53

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

108

1.39

0.53

1.8

1.4

37.0

52.7

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.45

0.53

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

305

0.79

0.52

1.1

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

656

1.14

0.52

1.2

1.3

nmol/l

1.6

1.5

0.37

596

(3022313) Gas panel - Capillary blood

344

3242

1.06

0.52

3.3

3.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

286

1.22

0.52

1.1

—

(3028433) Virus identified in Specimen by Culture

259

1.24

0.52

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.45

0.51

1.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.50

0.51

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

846

1.12

0.51

1.2

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

140

1275

1.10

0.51

4.2

3.5

1.4

1.5

0.20

103

989

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

379

1.19

0.50

1.4

1.7

—

(3030313) Adrenal Ab [Titer] in Serum

1.46

0.50

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

840

0.88

0.49

1.6

1.4

e6/l

1536.4

2282.3

1.40

609

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

508

0.85

0.49

1.7

—

(3014271) Vancomycin [Susceptibility]

381

1.18

0.48

3.2

2.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

119

1080

1.10

0.47

1.3

—

(3017509) Phencyclidine [Presence] in Urine

1.49

0.47

4.9

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

374

3938

0.95

0.46

9.0

mmol/l

24.3

24.4

0.18

343

3686

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.46

0.46

1.1

1.0

—

(3024928) Oxygen saturation in Venous blood

165

1523

1.08

0.46

2.8

3.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

112

1015

1.10

0.46

1.3

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

173

1.27

0.46

9.1

7.8

—

(3008295) Osmolality of Serum or Plasma

787

1.12

0.46

1.7

1.4

mosm/kgh2o

277.9

278.0

0.01

600

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

430

1.16

0.46

1.1

u/l

79.6

85.9

0.32

327

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

129

1.32

0.45

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

187

0.75

0.45

1.4

1.3

mu/l

12.9

74.1

—

139

(3017315) Amylase [Enzymatic activity/volume] in Urine

412

1.17

0.45

1.1

1.3

u/l

361.4

295.9

0.13

383

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

116

1056

1.10

0.44

1.5

1.4

—

(4024509)

818

1.11

0.44

1.8

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

193

2071

0.93

0.44

1.2

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

947

0.90

0.44

1.0

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

131

1201

1.09

0.44

2.0

1.9

mmol/l

1.6

1.7

0.18

131

1173

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

229

1.22

0.43

3.0

3.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

109

991

1.10

0.43

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

128

0.70

0.43

2.7

3.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

193

1.24

0.43

1.2

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

193

1.24

0.43

1.3

1.4

g/l

9.8

12.7

0.99

147

(3042631) Mycobacterium sp identified in Specimen

113

1030

1.10

0.43

2.6

2.7

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.56

0.42

1.0

1.1

mg/l

0.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

107

974

1.10

0.42

1.8

90.0

89.7

0.21

107

961

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

194

1.24

0.41

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

194

1.24

0.41

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

194

1.24

0.41

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

194

1.24

0.41

1.0

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.35

0.41

1.2

mmol/l

4.5

6.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.52

0.41

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.41

0.0

3.3

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.41

0.0

7.8

—

53.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.9

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.41

0.0

1.3

—

2772.9

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.41

0.0

8.1

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.41

0.0

6.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

250

0.80

0.41

1.6

2.0

e6/l

1690.5

16970.7

—

136

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

231

1.21

0.41

1.5

1.3

6.8

27.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

314

1.18

0.41

1.8

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

314

1.18

0.41

1.8

2.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

103

938

1.10

0.40

3.0

3.4

nmol/l

5.4

11.6

0.50

914

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.39

0.40

1.1

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

653

1.12

0.40

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

223

1.21

0.39

1.3

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.39

0.0

1.5

—

44.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

301

2861

1.05

0.39

3.1

3.4

u/ml

459.7

2326.8

1.15

252

2416

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

187

1.23

0.38

1.1

1.3

nmol/l

169.3

130.7

0.84

134

(3051611) Lipemic interference index of Serum or Plasma

817

1.10

0.38

2.7

3.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

948

0.91

0.38

1.0

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

307

1.17

0.38

2.1

2.2

umol/l

56.0

0.01

247

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

129

1192

1.08

0.38

1.4

1.3

nmol/l

0.2

0.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

905

0.91

0.38

1.6

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

118

1087

1.09

0.37

1.4

1.2

u/ml

3.2

3.8

0.22

357

(3051101) Glucose [Moles/volume] in Cord blood

136

0.73

0.37

6.1

6.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

234

1.20

0.37

1.2

1.8

—

(3046861) Legionella sp Ag [Presence] in Urine

1.35

0.37

1.0

—

(3013727) Leukocytes other/100 leukocytes in Blood

257

0.82

0.37

6.5

3.3

44.5

52.3

0.82

247

(3011288) Drugs identified in Urine by Screen method

120

1108

1.08

0.36

1.9

3.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

300

0.83

0.36

25.8

33.2

ug/l

7.2

7.3

0.09

272

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

318

1.16

0.36

1.2

2.0

144.8

155.3

0.45

294

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

318

1.16

0.36

1.8

2.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

158

1476

1.07

0.36

5.0

5.3

iu/ml

322.6

579.5

0.79

203

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

198

1.21

0.36

1.0

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

912

0.91

0.36

2.8

2.3

mmol/l

105.5

105.4

0.03

902

(3041354) Potassium [Moles/volume] in Venous blood

912

0.91

0.36

2.8

2.3

mmol/l

4.0

0.01

902

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

375

1.15

0.35

1.1

u/l

1.1

0.04

182

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.43

0.35

1.0

mmol/l

8.6

8.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

517

1.12

0.35

1.3

1.2

u/l

33.5

22.4

0.60

433

(3038071) Oxygen [Partial pressure] in Mixed venous blood

153

1.24

0.35

9.7

7.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

188

1771

1.06

0.34

2.4

ug/min

90.4

94.6

0.07

107

1040

(40768800) Prostate Pathology biopsy report

102

1107

0.92

0.34

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

547

1.12

0.34

1.5

1.6

u/l

5.6

6.0

0.09

265

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.34

0.34

1.1

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

689

0.90

0.34

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.33

0.33

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.32

0.33

2.4

2.8

u/field

0.6

0.7

0.18

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

156

1663

0.94

0.33

3.4

3.7

u/ml

23.6

38.3

2.73

151

1610

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

237

1.18

0.33

2.4

2.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

237

1.18

0.33

2.4

2.9

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

133

0.75

0.33

1.1

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

604

0.89

0.33

2.2

2.1

u/field

2.6

2.1

0.17

247

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.30

0.33

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

253

0.83

0.33

1.3

1.5

mmol/l

7.5

8.3

0.56

146

(3033705) Calcium.ionized [Moles/volume] in Venous blood

896

0.91

0.32

2.9

2.3

—

(40768806) Pleura Pathology biopsy report

750

0.91

0.32

1.7

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

817

1.09

0.32

1.4

nmol/l

0.3

0.41

595

(3016038) Potassium [Moles/volume] in Urine

511

1.12

0.32

1.1

mmol/l

35.3

33.7

0.18

431

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

137

1.24

0.32

1.5

2.6

—

(3000034) Microalbumin [Mass/volume] in Urine

722

1.10

0.32

2.7

3.0

mg/l

48.5

46.9

0.02

521

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

110

1.27

0.31

2.5

2.0

umol/l

12.1

17.9

1.43

110

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

348

0.86

0.31

2.7

2.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

361

1.14

0.31

1.9

2.1

ug/min

74.4

182.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

437

1.12

0.31

1.3

1.6

ug/l

2.5

5.2

1.34

339

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.71

0.30

1.6

5.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

100

0.70

0.30

5.3

9.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

100

0.70

0.30

3.6

1.9

—

(3012441) Differential panel - Pleural fluid

715

0.91

0.30

1.6

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

482

4670

1.03

0.29

3.0

3.8

u/ml

45.0

63.0

1.02

459

4491

(3047189) Immunofixation for 24 hour Urine

356

0.87

0.29

1.7

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1065

0.93

0.29

1.6

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

106

0.75

0.29

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

106

0.75

0.29

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

106

0.75

0.29

1.0

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.23

0.29

1.0

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

535

1.10

0.28

1.3

1.2

u/l

98.1

85.7

0.48

464

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

195

0.82

0.28

1.6

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

260

1.15

0.28

2.0

2.7

umol/l

25.9

28.6

0.83

188

(3044007) Cell count panel - Peritoneal fluid

227

0.84

0.28

2.5

2.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

103

1.26

0.28

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.32

0.28

1.3

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

742

0.92

0.28

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

796

1.08

0.27

1.8

1.7

—

(3044009) aPTT.lupus sensitive (LA screen)

1.27

0.27

1.1

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

741

0.92

0.27

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

177

1.19

0.27

1.7

1.8

—

(3035933) Granulocytes/100 leukocytes in Blood

183

0.82

0.27

1.3

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

280

1.14

0.27

1.5

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

122

1.23

0.27

1.3

—

(3019174) dRVVT (LA screen)

1.21

0.26

1.1

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.21

0.26

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.21

0.26

1.3

2.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

272

1.14

0.26

1.1

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

488

4743

1.03

0.26

7.8

8.7

1.4

0.17

483

4710

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

738

0.92

0.25

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

738

0.92

0.25

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

509

0.90

0.25

6.5

6.1

—

(3012501) Base excess in Blood by calculation

175

1666

1.05

0.25

4.0

4.2

mmol/l

2.3

2.6

0.66

134

1185

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

723

1.08

0.25

3.1

2.9

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

602

0.91

0.25

1.7

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.20

0.25

1.1

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

292

1.13

0.25

1.0

u/ml

0.4

2.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.73

0.24

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

766

0.93

0.24

1.2

1.1

94.0

96.0

0.26

719

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

360

0.89

0.24

4.7

3.4

—

(4211845)

398

1.11

0.23

3.4

3.5

—

(3000764) Benzodiazepines [Presence] in Urine

174

1661

1.05

0.23

1.6

2.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

143

1359

1.05

0.23

1.4

—

(44806420)

218

1.15

0.23

2.6

2.4

—

(3051593) INR in Capillary blood by Coagulation assay

342

1.11

0.22

7.1

10.9

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

200

0.85

0.22

1.2

pmol/l

195.0

310.0

—

144

(3015183) Erythrocyte sedimentation rate

304

1.12

0.22

2.1

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.25

0.22

8.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

660

1.08

0.22

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

660

1.08

0.22

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

660

1.08

0.22

1.5

1.7

—

(3024932) HLA-DR beta [Type]

221

0.86

0.22

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

337

0.89

0.22

1.3

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

153

1.18

0.22

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

587

0.92

0.22

1.1

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.27

0.22

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.27

0.22

2.2

2.0

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.22

0.22

1.0

u/field

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.22

0.22

1.2

1.5

umol/24h

227.2

338.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

1.2

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.21

0.0

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.21

0.0

1.2

—

(3027008) Opiates [Presence] in Urine

174

1667

1.04

0.21

1.6

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

123.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

173

1.16

0.20

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.4

—

1.9

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

152

1455

1.05

0.20

3.2

3.1

nmol/l

0.8

1.43

110

1115

(3048929) Epstein Barr virus Ab [Presence] in Serum

175

1821

0.96

0.19

1.3

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

772

1.06

0.19

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.18

0.19

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.18

0.19

1.3

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

539

1.08

0.19

1.0

ng/l

332.3

341.4

0.08

383

(3051651) Icteric interference index of Serum or Plasma

452

1.08

0.19

2.8

3.4

—

(3011985) Renin [Units/volume] in Plasma

114

1085

1.05

0.19

1.8

1.4

mu/l

51.7

57.0

0.23

102

965

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.15

0.19

1.3

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

184

1.14

0.19

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

154

0.84

0.19

1.6

3.5

ng/l

105.4

138.5

—

(3028300) Cannabinoids [Presence] in Urine

174

1674

1.04

0.18

1.6

2.1

—

(4268621)

744

1.06

0.18

2.6

2.3

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.21

0.18

1.0

1.1

—

9.8

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

541

1.07

0.18

1.0

ng/l

821.1

717.3

0.87

373

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

204

1.13

0.18

1.2

3.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

309

3008

1.03

0.17

2.0

1.9

ug/l

2.2

2.3

0.07

261

2673

(44790047)

825

1.06

0.17

1.7

1.5

—

(44790049)

825

1.06

0.17

1.7

1.5

—

(44806118)

825

1.06

0.17

1.7

1.5

—

(44790048)

825

1.06

0.17

1.7

1.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

351

0.91

0.17

1.1

u/ml

4.3

6.0

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.76

0.17

1.8

1.2

mg/l

11.4

8.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

152

0.86

0.16

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

152

0.86

0.16

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

777

1.06

0.16

1.3

—

(4306422)

110

1051

1.05

0.16

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

234

1.11

0.16

1.7

—

(3050794) Legionella sp Ab [Presence] in Serum

1.18

0.16

1.3

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

437

4462

0.98

0.16

6.4

6.9

mmol/l

24.9

0.00

432

4431

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

398

1.08

0.16

1.3

1.4

pmol/l

48.8

138.0

0.63

126

(3024891) Influenza virus A+B Ag [Presence] in Specimen

182

1760

1.03

0.16

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

544

1.07

0.16

1.0

ng/l

40.2

44.0

0.33

379

(4212803)

1.11

0.16

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

111

1.17

0.15

1.2

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.10

0.15

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

506

1.07

0.15

1.4

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

168

1.13

0.15

1.1

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

380

0.92

0.15

3.3

3.4

mu/l

30.1

26.6

0.21

364

(3027035) Albumin [Mass/time] in 24 hour Urine

1.13

0.15

1.3

—

577.7

—

(40768793) Breast Pathology biopsy report

212

2061

1.03

0.14

1.3

—

(3006462) Nitrate [Presence] in Urine

372

1.08

0.14

3.6

—

(3004775) Volume in Urine collected for unspecified duration

583

0.94

0.14

2.2

2.3

711.3

638.6

0.35

392

(3014891) Appearance of Pleural fluid

0.83

0.13

1.6

1.5

—

(4198724)

211

0.90

0.13

3.6

2.6

—

(3024263) Appearance of Synovial fluid

413

1.07

0.13

1.3

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

229

1.09

0.12

1.1

—

(40768795) Lymph node Pathology biopsy report

824

0.96

0.12

1.1

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

415

0.94

0.11

1.5

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

191

1864

1.03

0.11

3.0

3.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

211

2062

1.02

0.11

2.5

g/l

3.7

3.6

0.20

197

1960

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

178

0.90

0.11

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

124

1.13

0.11

1.4

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

105

1016

1.03

0.10

1.3

pmol/l

306.6

303.3

0.03

776

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

125

1214

1.03

0.10

1.4

u/ml

109.5

118.8

0.59

256

(3026470) Cobalt [Mass/volume] in Blood

515

1.05

0.10

2.1

2.0

ug/l

2.4

3.6

0.88

450

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

849

8571

0.99

0.10

3.3

4.0

ug/l

25.3

21.9

0.09

663

6944

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

183

1.09

0.10

1.0

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

337

3424

0.98

0.10

3.0

4.1

mmol/l

24.1

24.3

0.99

299

3081

(3033799) Differential panel - Peritoneal fluid

242

1.07

0.09

1.9

2.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

141

1375

1.03

0.09

2.2

2.1

u/l

6166.3

3939.0

0.28

565

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

174

1.09

0.09

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

252

1.07

0.09

1.1

—

(3024471) HLA-A [Type]

227

0.92

0.09

1.0

—

(3003694) ABO and Rh group [Type] in Blood

1929

19389

0.99

0.09

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

134

0.90

0.08

1.7

1.6

—

(3011648) Oxygen content in Venous blood

597

1.04

0.08

1.7

2.1

11.8

11.0

0.94

597

(40757373) Influenza virus identified in Isolate

144

0.90

0.08

1.1

1.6

—

(3000991) Gas panel - Venous blood

607

6127

0.99

0.08

7.3

8.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.06

0.08

3.3

2.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

549

1.04

0.07

3.6

2.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.12

0.07

1.5

1.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.83

0.07

1.8

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.08

0.07

2.5

2.1

—

(3010421) pH of Blood

198

1947

1.02

0.07

3.9

4.1

7.4

0.12

171

1637

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

146

1431

1.02

0.07

1.5

1.8

nmol/l

0.9

0.8

0.54

109

1193

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

340

3359

1.01

0.07

2.3

2.8

0.7

0.23

325

3224

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

108

1.11

0.07

1.7

1.4

3.0

9.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

254

2504

1.01

0.07

2.7

3.1

u/ml

0.3

0.4

0.08

137

1438

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.86

0.07

1.1

1.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

926

1.03

0.07

2.5

2.2

32.9

32.7

0.20

920

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.84

0.07

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.05

0.07

1.0

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1014

0.98

0.07

1.2

1.1

121.4

118.7

0.47

912

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

630

0.97

0.06

1.9

1.8

mg/l

3.5

4.1

0.33

597

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.84

0.06

1.1

1.0

—

(3025577) Chromium [Mass/volume] in Blood

502

1.04

0.06

2.2

2.1

ug/l

1.9

2.5

0.97

425

(40765089) Chromosome analysis panel - Blood by G-banded

101

0.89

0.06

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

102

0.88

0.06

1.0

1.2

—

(3018133) Calcium [Moles/volume] in Urine

105

0.86

0.06

1.1

1.9

mmol/l

1.4

2.7

—

(1761868) Lipid panel - Serum or Plasma

2541

25488

1.00

0.06

3.1

2.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

647

6516

0.99

0.06

6.3

6.8

mmol/l

1.4

1.3

0.52

626

6298

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.11

0.05

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.11

0.05

3.3

2.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

128

1302

0.98

0.05

1.5

2.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

524

1.03

0.05

1.1

1.2

mg/l

41.9

40.9

0.06

439

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

100

1.10

0.05

1.0

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

335

3381

0.99

0.05

1.8

1.7

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

171

0.94

0.05

3.1

2.4

mmol/l

8.4

7.5

—

102

(3003129) Base excess in Capillary blood by calculation

191

0.94

0.04

1.9

1.8

mmol/l

-0.1

0.9

0.64

181

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

863

1.02

0.04

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

199

1.06

0.04

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

282

0.96

0.04

2.3

2.2

e6/l

392.2

5227.6

0.87

196

(3044242) Glucose [Moles/volume] in Arterial blood

377

1.03

0.04

1.4

2.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

108

1062

1.02

0.04

1.2

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

219

1.05

0.04

1.1

—

(3035880) pH of Pleural fluid

379

1.03

0.03

1.5

1.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

270

1.04

0.03

1.4

2.0

u/ml

8723.6

48115.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

220

2182

1.01

0.03

2.3

2.1

90.8

92.0

0.33

206

2039

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

189

0.95

0.03

1.3

1.2

ug/l

40.8

325.7

—

105

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

897

1.01

0.03

1.9

2.0

ug/l

14.4

23.3

5.19

883

(3020191) Ethanol [Moles/volume] in Serum or Plasma

529

1.02

0.03

1.3

1.5

promille

1.3

1.2

0.05

405

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

390

1.03

0.02

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

249

0.96

0.02

1.5

1.4

52.1

63.4

0.59

211

(3016750) Collection duration of Urine

420

0.98

0.02

1.8

2.2

min

482.6

496.7

0.42

312

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

199

2005

0.99

0.02

2.7

2.4

193.3

196.3

0.19

185

1907

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

480

0.98

0.02

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

490

0.98

0.02

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

108

1068

1.01

0.02

1.4

1.2

u/ml

3.3

4.4

0.47

463

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

510

1.02

0.02

1.0

1.1

mg/l

299.8

270.7

0.29

443

(1616796) Gas panel - Central venous blood

162

1607

1.01

0.02

3.8

3.7

—

(21494755) Public health laboratory ask at order entry panel

581

5829

1.00

0.02

1.4

—

(3002619) Bacteria identified in Specimen by Culture

147

0.95

0.01

1.6

1.3

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

889

0.99

0.01

1.3

—

34.2

—

(3016879) Cocaine [Presence] in Urine

155

1540

1.01

0.01

1.6

2.2

—

(3020650) Glucose [Presence] in Urine

187

0.96

0.01

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

552

1.01

0.01

1.2

1.3

mmol/l

11.6

12.0

0.10

152

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

213

1.03

0.01

1.3

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

638

0.99

0.01

1.4

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

712

1.01

0.01

4.4

4.9

u/ml

227.4

93.1

0.42

199

(3034426) Prothrombin time (PT)

257

0.97

0.01

1.4

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

742

1.01

0.01

1.9

1.8

—

(3027944) Amphetamines [Presence] in Urine

164

1631

1.01

0.01

1.6

2.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

323

1.02

0.01

1.4

2.0

umol/l

43.1

130.6

4.44

169

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

146

0.96

0.00

1.0

1.1

—

5.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

214

1.03

0.00

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

107

1064

1.01

0.00

1.1

iu/ml

50.9

10015.0

0.55

239

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

119

1196

0.99

0.00

1.2

1.3

u/l

24.1

37.0

2.00

1046

(40758292) HTLV I+II Ab panel - Serum

113

0.97

0.00

1.6

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

167

1.02

0.00

1.1

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

223

0.99

0.00

1.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

357

1.01

0.00

3.8

3.9

—

(4027681)

393

0.99

0.00

1.2

—

(4133840)

166

1.02

0.00

1.1

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

467

1.01

0.00

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

276

1.01

0.00

1.6

1.4

—

1782790.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

145

0.97

0.00

2.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

175

1.03

0.00

1.2

—

(3048879) Bone marrow aspiration report

225

0.98

0.00

2.2

1.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

225

0.98

0.00

1.1

—

(3005033) Fetal Nuchal fold Thickness US

615

1.01

0.00

1.4

—

(3036489) Thrombin time

269

2695

1.00

0.00

2.1

2.0

21.2

21.6

0.52

230

2364

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

118

1.02

0.00

1.3

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

170

1701

1.00

0.00

2.9

3.4

u/ml

538.0

601.1

0.05

154

1544

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

391

1.00

0.00

1.8

1.9

u/field

2.8

2.6

0.08

276

(3047352) Trisomy 18 risk [Likelihood] in Fetus

619

1.00

0.00

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.01

0.00

1.6

1.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

109

1.01

0.00

2.9

3.0

—

26.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

151

0.99

0.00

7.9

5.0

u/l

35.5

65.8

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.3

—

10.6

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.99

0.00

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.88

0.00

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.5

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.89

0.00

2.4

4.6

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

5.6

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

0.0

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.91

0.00

2.7

2.3

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.96

0.00

1.2

1.3

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.01

0.00

2.2

3.3

umol/l

28.8

40.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.93

0.00

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.93

0.00

1.1

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.86

0.00

1.2

1.0

—

(3012898) Urea [Moles/volume] in Urine

0.91

0.00

1.1

1.4

mmol/l

189.3

164.9

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.02

0.00

1.6

2.1

umol/l

1.5

1.4

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

0.91

0.00

1.3

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.92

0.00

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

0.91

0.00

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

17.6

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.95

0.00

1.9

1.5

umol/l

60.9

44.1

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.8

—

14.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_LICHEN_PLANUS_WIDE and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_LICHEN_PLANUS_WIDE	0.843 [0.76, 0.93]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.143

During the follow-up period (1.1.1998 — 31.12.2019), 2485 out of 24901 females with K11_LICHEN_PLANUS_WIDE died.

Males

Parameter	HR [95% CI]	p-value
K11_LICHEN_PLANUS_WIDE	0.832 [0.74, 0.93]	0.001
Birth year	0.988 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 1561 out of 13401 males with K11_LICHEN_PLANUS_WIDE died.

Mortality risk

Mortality risk for people of age

years, who have K11_LICHEN_PLANUS_WIDE.

N-year risk	Females	Males
1	0.077%	0.16%
5	0.43%	1.002%
10	1.069%	2.575%
15	2.15%	4.734%
20	4.047%	8.05%

Relationships between endpoints

↥

Index endpoint: K11_LICHEN_PLANUS_WIDE – Lichen ruber planus, wide definition including periferal and oral lichen planus

GWS hits: 15

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Lichen ruber planus, wide definition including periferal and oral lichen planus

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints